Preoperative Risk-Assessment Methods, Short-Term Outcome, and Patient Satisfaction in Elective Cranial Neurosurgery by Reponen, Elina
 Department of Anaesthesiology, Intensive Care and Pain Medicine
Department of Neurosurgery
University of Helsinki and Helsinki University Hospital
Helsinki, Finland
PREOPERATIVE RISK-ASSESSMENT METHODS, 
SHORT-TERM OUTCOME, AND 
PATIENT SATISFACTION IN ELECTIVE 
CRANIAL NEUROSURGERY
Elina Reponen
ACADEMIC DISSERTATION
To be presented with the permission of the Medical Faculty of  
the University of Helsinki, for public examination in the auditorium of  
Peijas Hospital, Sairaalakatu 1, 
on January 9th 2016, at 10 am.
HELSINKI 2015
 Supervisors
Docent Miikka Korja, MD, PhD
Department of Neurosurgery,
University of Helsinki and Helsinki University Hospital
Helsinki, Finland
Hanna Tuominen, MD, PhD
Department of Anaesthesiology, Intensive Care and Pain Medicine
University of Helsinki and Helsinki University Hospital
Helsinki, Finland
Reviewers
Professor Risto P. Roine, MD, PhD
Department of Health and Social Management
University of Eastern Finland
Kuopio, Finland
Docent Minna Niskanen, MD, PhD
Department of Anaesthesia
Kuopio University Hospital
Kuopio, Finland
Official opponent
Professor Pekka Talke, MD, PhD
Department of Anesthesia and Perioperative Care
University of California San Francisco
San Francisco, California, USA
Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam  
Universitatis Helsinkiensis
ISBN 978-951-51-1756-4 (paperback)
ISSN 2342-3161 (print)
ISBN 978-951-51-1757-1 (PDF)
ISSN 2342-317X (online)
http://ethesis.helsinki.fi
Grano Oy
Jyväskylä, 2015
Finland
 To Pade, Emil and Joel
 CONTENTS 
 
 LIST OF ORIGINAL PUBLICATIONS ........................................................ 7
 ABBREVIATIONS .......................................................................................8
 ABSTRACT  .............................................................................................. 10
 TIIVISTELMÄ ........................................................................................... 12
1 INTRODUCTION ...................................................................................... 14
2 REVIEW OF THE LITERATURE  ............................................................. 16
 2.1 Preoperative evaluation of elective craniotomy patients .............. 16
  2.1.1 Organization of preoperative evaluation ........................... 16
  2.1.2 Patient history .................................................................... 16
  2.1.3 Clinical evaluation .............................................................. 18
  2.1.4 Laboratory measurements ................................................. 19
  2.1.5 Radiological imaging .......................................................... 19
 2.2 Preoperative risk-prediction scores in surgery .............................20
  2.2.1 Development of risk-prediction scores .............................20
  2.2.2 Challenges of risk prediction scores and  
   their implementation in clinical practice ...........................20
  2.2.3 Example of customized risk prediction: The EuroScore ... 21
 2.3 Proposed scales for preoperative  
  evaluation of elective craniotomy patients ....................................23
	 	 2.3.1	 ASA	Physical	Status	Classification .....................................23
  2.3.2 Karnofsky Performance Score (KPS) .................................24
  2.3.3 mRS score ...........................................................................25
  2.3.4 Charlson comorbidity score ...............................................25
  2.3.5 SKALE score .......................................................................26
  2.3.6 Other scores ........................................................................27
   2.3.6.1 POSSUM and P-POSSUM....................................27
   2.3.6.2 ECOG Performance Status ...................................27
 2.4 Scales measuring cognitive function .............................................28
  2.4.1 MMSE .................................................................................28
  2.4.2 Test Your Memory (TYM) ..................................................28
 2.5 Outcome of elective craniotomy patients .......................................29
  2.5.1 Short-term morbidity and mortality .................................29
  2.5.2 Long-term morbidity and mortality .................................. 31
  2.5.3 The mRS as a proxy for surgical outcome ......................... 31
  2.5.4 Quality of life ......................................................................32
  2.5.5 Patient-reported outcomes (PROs) and  
   patient-reported outcome measures (PROMs) .................32
  2.5.6 Patient satisfaction .............................................................33
 3 AIMS OF THE PRESENT STUDY ..........................................................34
4 PATIENTS AND METHODS  35
 4.1 Methods of the systematic review (I) .............................................35
 4.2 Patients (II-V) .................................................................................35
 4.3 Methods (II-V) .................................................................................40
  4.3.1 Study design .......................................................................40
  4.3.2 Study protocol and data collection ....................................40
  4.3.3 Preoperative variables and scores .....................................42
  4.3.4 Perioperative variables .......................................................44
  4.3.5 Postoperative in-hospital variables and scores .................44
  4.3.6 30-day outcome variables and scores ................................45
  4.3.7 Study outcome measures ...................................................45
	 	 	4.3.7.1	 New	CNS	deficits	(II) ...........................................46
   4.3.7.2 Systemic and infectious complications (II) .........46
   4.3.7.3 Major morbidity (III, IV, V) .................................46
   4.3.7.4 Overall morbidity (III, IV, V) ...............................46
  4.3.8 Statistical methods .............................................................48
   4.3.8.1 Pearson Chi Square test .......................................48
   4.3.8.2 Fisher’s Exact test.................................................48
   4.3.8.3 Odds ratio .............................................................49
   4.3.8.4 Mann-Whitney U-test ..........................................49
   4.3.8.5 Kruskall-Wallis test ..............................................49
   4.3.8.6 Linear and logistic regression analyses ...............50
	 	 	4.3.8.7	 Sensitivity,	specificity,	positive	predictive	 
    value (PPV), and negative predictive  
    value (NPV) ..........................................................50
   4.3.8.8 Receiver operating characteristics (ROC)  
    curve and area under the curve (AUC) ................ 51
  4.3.9 Ethical aspects .................................................................... 51
5 RESULTS ..................................................................................................52
 5.1 Results of the systematic review (I) ...............................................52
	 	 5.1.1	 ASA	Physical	Status	Classification	score ...........................52
  5.1.2 KPS score ............................................................................53
  5.1.3 mRS score ...........................................................................54
  5.1.4 Charlson comorbidity score ...............................................54
  5.1.5 SKALE score .......................................................................55
 5.2 Short-term postoperative complications  
  (II, III, IV) and complication phenotypes (III) .................................56
  5.3 Outcome measures .........................................................................59
	 	 5.3.1	 New	CNS	deficits	(II) .........................................................59
  5.3.2 Systemic and infectious complications (II) .......................59
  5.3.3 Major morbidity (III-V) .....................................................59
  5.3.4 Overall and minor morbidity (III-V) .................................59
  5.3.5 In-hospital and 30-day mortality (II-V) ............................59
  5.3.6 Length of stay (LOS) ..........................................................62
   5.3.6.1 ICU LOS (II) .........................................................62
   5.3.6.2 Hospital LOS (II) ..................................................62
 5.4 Preoperative risk-assessment methods .........................................62
  5.4.1 Preoperative risk-assessment scores .................................62
   5.4.1.1 ASA Physical Status score (II) .............................62
   5.4.1.2 Helsinki ASA score (II) ........................................63
   5.4.1.3 mRS score .............................................................55
   5.4.1.4 Charlson comorbidity score .................................66
  5.4.2 Patient characteristics, patient-reported preoperative  
   variables and preoperative laboratory measurements (II) ..67
  5.4.3 Composite preoperative risk predictors (II) .....................70
 5.5 Postoperative in-hospital assessments ..........................................72
  5.5.1 mRS at hospital discharge (III) .........................................72
  5.5.2 Postoperative patient-reported outcomes (V)...................74
 5.6 30-day follow-up assessments .......................................................76
  5.6.1 mRS at 30 days (III) ...........................................................76
  5.6.2 Patient-reported outcomes at 30 days and composite  
   scores of postoperative patient-reported outcomes (V) ....79
  5.6.3 Patient satisfaction at 30 days (IV) .................................. 80
6 DISCUSSION ...........................................................................................82
 6.1 Preoperative risk-assessment methods .........................................82
 6.2 Outcomes and outcome reporting ...................................................87
 6.3 Patient satisfaction .........................................................................90
 6.4 Limitations of the study ..................................................................92
7 CLINICAL IMPLICATIONS AND FUTURE PERSPECTIVES ................98
8 CONCLUSIONS ......................................................................................100
9 ACKNOWLEDGEMENTS ....................................................................... 101
10 REFERENCES ........................................................................................104
11 APPENDICES ..........................................................................................115
Original publications .......................................................................................118
7 
 LIST OF ORIGINAL PUBLICATIONS
This thesis is based on the following original publications. In the text 
they are referred to by their Roman numerals (I-V). Articles have been 
reprinted with the kind permission of their copyright holders. In addi-
tion, this thesis presents some unpublished results.
I  Reponen E, Tuominen H, Korja M. Evidence for the use of pre-
operative risk assessment scores in elective cranial neurosurgery: 
a systematic review of the literature. Anesthesia & Analgesia 
2014;119(2):420-32.
II Reponen E, Korja M, Niemi T, Silvasti-Lundell M, Hernesniemi J, 
Tuominen	H.	Preoperative	identification	of	neurosurgery	patients	
with a high risk of in-hospital complications –a prospective cohort 
of 418 consecutive elective craniotomy patients. Journal of Neuro-
surgery 2015;123(3):594-604.
III	 Reponen	E,	Tuominen	H,	Hernesniemi	J,	Korja	M.	Modified	Rankin	
Scale is a widely used but unreliable outcome measure in cranial 
neurosurgery - a prospective and unselected cohort study. Submit-
ted.
IV Reponen E, Tuominen H, Hernesniemi J, Korja M. Patient satis-
faction and short-term outcome in elective cranial neurosurgery. 
Neurosurgery 2015;77(5):769-776.  
V Reponen E, Tuominen H, Hernesniemi J, Korja M. Patient-reported 
outcomes in elective cranial neurosurgery. World Neurosurgery. 
Published online ahead of print August 14, 2015.
8 
 ABBREVIATIONS
AANS American Association of Neurological Surgeons
ACS American College of Surgeons
AMI acute myocardial infarction
ANOVA analysis of variance
aPTT activated partial thromboplastin time
ASA American Society of Anesthesiologists 
AUC area under the curve
AV atrioventricular
BMI Body Mass Index
CAD  coronary artery disease
CI		 confidence	interval
CNS central nervous system
COPD chronic obstructive pulmonary disease
CPT  Current Procedural Terminology
Crea creatinine
CRP C-reactive protein
CRT craniotomy
CSF	 cerebrospinal	fluid
DBP diastolic blood pressure
DVT deep venous thromboembolism
ECOG Eastern Cooperative Oncology Group
EI endovascular intervention
EUROHIS-QOL European Health Interview Survey –Quality of Life
EuroSCORE European System for Cardiac Operative Risk Evaluation 
Gluc blood glucose
Hb  hemoglobin
HR  heart rate
IBM® International Business Machines
ICP intracranial pressure
ICU  intensive care unit
K potassium
KPS Karnofsky Performance Score
LMWH low molecular weight heparin
LOS length of stay
Mac OS® Macintosh Operating System
MCH mean cell hemoglobin
MCHC mean cell hemoglobin concentration
9 
MCV mean cell volume
MET metabolic equivalent
MMSE Mini-Mental State Examination
MRI magnetic resonance imaging
mRS	 modified	Rankin	Scale
MS® Microsoft
Na sodium
NICE National Institute for Health and Care Excellence
NPV negative predictive value
N2QOD  National Neurosurgery Quality and Outcomes Database
NSQIP National Surgical Quality Improvement Program
OR  odds ratio/operating room
PCOR Patient-Centered Outcomes Research
PE pulmonary embolism
PMI perioperative myocardial infarction
PONV postoperative nausea and vomiting
POSSUM Physiological and Operative Severity Score for the 
 enUmeration of Mortality and Morbidity
P-POSSUM Portsmouth Physiological and Operative Severity Score 
 for the enUmeration of Mortality and Morbidity
PPV  positive predictive value
PREM Patient-Reported Experience Measure
PRO Patient-Reported Outcome
PROM Patient-Reported Outcome Measure
PT plasma prothrombin time
QOL  quality of life
RCT randomized controlled trial
ROC receiver operating characteristics
SBP systolic blood pressure
SD  standard deviation
SKALE Sex, Karnofsky, ASA, Location, and Edema score
SPSS® Software Package for Statistics and Simulation
SVD subjective visual disturbances
TYM Test Your Memory 
UTI urinary tract infection
WI wound infection
WHODAS-12 World Health Organization Disability Assessment 
 Schedule 12-item version
WPW	 Wolff-Parkinson-White
10
Abstract
 ABSTRACT
 Aims
One objective of this study was to systematically review the current 
literature as to the use of preoperative risk-assessment scores in elective 
cranial neurosurgery. Other objectives were to study preoperative vari-
ables and scores in predicting short-term outcome, the reliability of the 
modified	Rankin	Scale	(mRS)	and	of	patient-reported	outcomes	(PROs)	
in short-term outcome reporting, and to study patient satisfaction in, 
to	our	knowledge,	the	first-ever	unselected,	prospective	cohort	of	adult	
elective craniotomy patients.
 Patients and Methods
First,	we	performed	a	systematic	review	of	25	studies	on	five	preopera-
tive scores [The American Society of Anesthesiologists’ physical status 
classification	(ASA)	score,	the	Karnofsky	Performance	Score	(KPS),	
the	modified	Rankin	Scale	(mRS),	the	Sex,	Karnofsky,	ASA,	Location,	
and Edema (SKALE) score, and the Charlson comorbidity score] in 
predicting outcome in elective cranial neurosurgery.
We enrolled a prospective, unselected cohort of 418 adult elective 
craniotomy patients in the Department of Neurosurgery, Helsinki Uni-
versity Hospital. Evaluation of routinely collected preoperative data, 
original ASA score, Helsinki ASA score, and their combinations revealed 
their ability to predict in-hospital new central nervous system (CNS) 
deficits	as	well	as	systemic	and	infectious	complications	after	elective	
craniotomy. Furthermore, we evaluated the reliability and accuracy of 
patient-reported outcomes, postoperative mRS scores, and mRS-score 
differences	in	reflecting	short-term	outcome.	Overall	patient	satisfaction	
rate was determined, as were associations between high or low patient 
satisfaction and short-term postoperative outcome.
 Results 
Evidence as to the applicability of preoperative risk-assessment scores 
in elective cranial neurosurgery is scarce, with KPS receiving the most 
support in the literature. However, both ASA score and Charlson comor-
bidity	score	received	support	for	risk	stratification	in	selected	patient	
cohorts. Furthermore, none of the scores predicted all postoperative 
outcomes; the most applicable risk score varied with the outcome 
measure selected.
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The in-hospital mortality rate was 1.0% and the 30-day rate was 2.4%. 
In-hospital systemic and infectious complications occurred in 6.7% of 
patients,	and	new	CNS	deficits	in	11.2%.	Advanced	age,	preoperatively	
elevated C-reactive protein (CRP) level, and high Helsinki ASA class 
were independent predictors of systemic and infectious complications. 
A	combination	of	these	variables	identified	one-fourth	of	the	patients	
with systemic and infectious complications and was associated with 
prolonged intensive care unit (ICU) stay (p=0.018) and hospital stay 
(p=0.004).
The rate of overall complications was 46.4%, and the rate of major 
complications was 18.2%. Perioperative changes in mRS scores were 
inconsistent: among patients with no complications, the mRS score 
increased for 17.1% at hospital discharge and for 23.8% at 30 days. 
Moreover, 28.0% of patients with major complications showed no 
increase in mRS scores at hospital discharge. Associations between 
patient-reported postoperative subjective deterioration in functional 
status	and	both	major	and	overall	morbidity	were	significant.	Further-
more, a simple unweighted composite score of PROs was more sensitive 
and	specific	than	was	30-day	dependent	functional	status	(mRS	score	
≥3)	in	detecting	both	major	and	overall	morbidity.
In our cohort, 93.8% rated their overall satisfaction as good or 
excellent. Even 9 of 10 patients with postoperative major morbidity 
rated their satisfaction as high. Low patient satisfaction was associated 
neither with major (p=0.054) nor with overall (p=0.215) morbidity. 
 Conclusions
Strong evidence supporting the use of any existing preoperative risk 
score in elective cranial neurosurgery is lacking. The Helsinki ASA score 
seems more suitable than the original ASA score for elective craniot-
omy patients, especially in combination with other preoperative risk 
predictors, but only for systemic and infectious complications. The rate 
of major complications in elective cranial neurosurgery was moderate 
or even low considering the average age, comorbidities and operated 
lesions of the patients in our unselected study cohort. The postoperative 
mRS	score	and	mRS-score	difference	were	unreliable	outcome	measures	
after elective craniotomy: the changes in mRS scores were inconsistent 
with regard to the presence or absence of complications. PROs seem 
to be promising tools for postoperative reporting of outcomes. Overall 
patient satisfaction in elective cranial neurosurgery was high, even in 
patients with complicated outcomes.
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 TIIVISTELMÄ
 Tavoitteet
Tutkimuksen tavoitteena oli arvioida systemaattisen katsauksen avulla 
tutkimusnäyttöä leikkausta edeltävien riskinarviointiluokitusten käytöstä 
aivoleikkauspotilailla. Lisäksi tavoitteena oli tutkia leikkausta edeltävien 
muuttujien ja luokitusten soveltuvuutta lyhytaikaishoitotulosten en-
nustamiseen,	modified	Rankin	Scalen	(mRS)	ja	potilaan	ilmoittamien	
hoitotulosten luotettavuutta lyhytaikaishoitotulosten mittaamisessa sekä 
potilastyytyväisyyttä ensimmäisessä aikuisista aivoleikkauspotilaista 
koostuvassa valikoimattomassa prospektiivisessa kohortissa.
 Potilaat ja Menetelmät
Teimme systemaattisen katsauksen 25 tutkimuksen tuloksista koskien 
viiden luokituksen [American Society of Anesthesiologists’ physical sta-
tus	classification	(ASA)	-luokitus,	Karnofsky	Performance	Score	(KPS)	
-luokitus,	modified	Rankin	Scale	(mRS)	-luokitus,	Sex,	Karnofsky,	ASA,	
Location, and Edema (SKALE) -luokitus ja Charlson comorbidity score 
-luokitus] käyttöä aivoleikkausta edeltävässä riskinarvioinnissa. 
Keräsimme prospektiivisesti 418 suunniteltuun aivoleikkaukseen 
tulevaa aikuispotilasta Helsingin yliopistollisen keskussairaalan Neu-
rokirurgian klinikassa. Tutkimuksessa arvioitiin leikkausta edeltävien 
rutiinimääritysten, ASA-luokituksen, Helsinki ASA -luokituksen ja 
yhdistelmämuuttujien soveltuvuutta keskushermostokomplikaatioiden 
sekä systeemi- ja infektiokomplikaatioiden ennustamiseen. Lisäksi sel-
vitimme leikkauksen jälkeisten potilaan ilmoittamien hoitotulosten, 
mRS-luokitusten ja mRS-luokkien muutosten luotettavuutta ja tark-
kuutta hoitotulosten mittaamisessa aivoleikkauspotilailla. Määritimme 
myös potilaiden kokonaistyytyväisyyden ja lyhytaikaishoitotulosten 
vaikutuksen tyytyväisyyteen. 
 Tulokset 
Tieteellistä näyttöä riskinarviointiluokitusten käytöstä suunnitellussa 
aivokirurgiassa on vähän. KPS-luokituksen käyttöä tukevaa näyttöä on 
eniten, mutta myös ASA-luokitus ja Charlson comorbidity score voivat 
soveltua valikoitujen potilasryhmien leikkausta edeltävään arviointiin. 
Mikään luokituksista ei ennustanut kaikkia hoitotuloksia; ennustea-
rviontiin parhaiten soveltuva luokitus vaihteli valitun hoitotuloksen 
mukaan. 
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Sairaalakuolleisuus oli 1,0 % ja 30 vuorokauden kuolleisuus 2,4 
%. Systeemi- ja infektiokomplikaatioita esiintyi 6,7 % ja keskusher-
mostokomplikaatioita 11,2 % potilaista. Korkea ikä, kohonnut C-reak-
tiivisen proteiinin (CRP) taso ja korkea Helsinki ASA -luokka olivat 
systeemi- ja infektiokomplikaatioiden itsenäisiä ennustetekijöitä. Yksi 
neljästä potilaasta jolla oli kaikki nämä ennustekijät sai systeemi-tai 
infektiokomplikaation ja tarvitsi pidempää tehohoitojaksoa (p=0.018) 
ja sairaalahoitoa (p=0.004). 
Komplikaatioita esiintyi yhteensä 46,4 % ja merkittäviä komplikaa-
tioita 18,2 % potilaista. Leikkauksenjälkeiset muutokset mRS-luokassa 
olivat epäjohdonmukaisia: mRS-luokka oli huonontunut kotiutumis-
vaiheessa 17,1 % ja 30 vuorokauden kohdalla 23,8 % potilaista, joilla 
ei todettu leikkauksen jälkeisiä komplikaatioita. Lisäksi mRS-luokan 
nousua ei todettu 28,0 % merkittäviä komplikaatioita saaneista po-
tilaista. Potilaslähtöisesti ilmoitetun toimintakyvyn huononemisen 
yhteys sekä merkittävien että kokonais-komplikaatioiden kanssa oli 
tilastollisesti merkitsevä. Lisäksi yksikertainen, painottamaton potilas-
lähtöinen yhdistelmämuuttuja oli 30 vrk kohdalla herkempi ja tarkempi 
tunnistamaan sekä merkittäviä että kokonaiskomplikaatioita kuin mRS 
luokka	≥3.	
Valtaosa (93,8 %) potilaista oli hyvin tai erittäin tyytyväisiä saamaan-
sa hoitoon, samoin jopa yhdeksän kymmenestä merkittäviä komp-
likaatioita saaneista. Tyytymättömyys hoitoon ei liittynyt merkittäviin 
(p=0.054) tai kokonaiskomplikaatioihin (p=0.215).
 Päätelmät
Vahva tieteellinen näyttö leikkausta edeltävien riskinarviointiluoki-
tusten käytöstä elektiivisessä aivokirurgiassa puuttuu. Helsinki ASA 
-luokitus vaikuttaa soveltuvan paremmin aivokirurgisten potilaiden sys-
teemi- ja infektiokomplikaatioiden riskin arviointiin kuin alkuperäinen 
ASA-luokitus, erityisesti yhdistettynä muihin leikkausta edeltäviin 
muuttujiin. Merkittäviä komplikaatioita on elektiivisessä aivokirurgi-
assa suhteellisen vähän huomioiden tutkimuspotilaiden ikä, sairaudet ja 
leikkausindikaatiot. Leikkauksenjälkeinen mRS-luokka tai mRS-luokan 
muutos kuvaa huonosti hoitotulosta: mRS-luokan muutokset olivat 
epäjohdonmukaisia suhteessa leikkauksenjälkeisiin komplikaatioihin. 
Potilaslähtöisesti ilmoitetut hoitotulokset ovat lupaavia tulevaisuud-
en hoitotulosmittareita. Kokonaispotilastyytyväisyys elektiivisessä 
aivokirurgiassa on korkea jopa merkittäviä komplikaatioita saaneilla 
potilailla. 
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1. INTRODUCTION
Modern neurosurgery emerged in the late 1800s propelled by three 
important inventions: general anesthesia, antisepsis, and the theory 
of cerebral localization.1 The next hundred years witnessed a rapid 
development of both surgical and anesthesiological techniques and of 
knowledge contributing to the state-of-the-art mini-invasive micro-
neurosurgery of today. The expanding possibilities of neurosurgical 
care have raised expectations of a good functional and even aesthetic 
outcome after elective cranial neurosurgery.
Intraoperative and postoperative morbidity plays an important 
role in determining quality of life and functional patient outcome 
and	has	a	major	impact	on	the	overall	cost-effectiveness	of	surgical	
treatment.2-4 Elective cranial neurosurgery is among the surgical 
subspecialties generally considered major surgery due to the high-
risk	profile	associated	with	the	vital	importance	of	the	brain	and	its	
delicate location inside the cranium. 
Preoperative risk-assessment scores are designed to help clini-
cians in anticipating a patient’s preoperative surgical risks. Several 
preoperative scores and models predict surgical outcome,5 but their 
widespread	use	has	been	limited	due	to	their	poor	specificity	and	
sensitivity. An optimal risk-assessment scale would be reliable, brief, 
straightforward,	objective,	specific,	and	sensitive.	
The American Society of Anesthesiologists’ (ASA) physical status 
classification	score	 is,	worldwide,	a	preoperative	risk	score,	even	
though it was not originally developed for this purpose.6-8 This score 
is a validated assessment score in predicting outcome after major ab-
dominal surgery, renal cell carcinoma surgery, general and vascular 
surgery, and spinal surgery,9-12 and it can also predict perioperative 
mortality in elective noncardiac surgery.13 Furthermore, some surgi-
cal subspecialties have succeeded in designing their own predictive 
preoperative models. For example, the European System for Cardiac 
Operative	Risk	Evaluation	(EuroSCORE)	risk	stratification	system	is	
standard in assessing risk for cardiac surgery patients.14, 15 The ASA 
score has, in fact, never been validated in elective cranial neurosur-
gery,	 and	no	neurosurgery-specific	preoperative	 risk-assessment	
scores exist.
Preoperative	risk	stratification	and	risk-assessment	scores	are	
necessary both for clinical and for administrative purposes. Such 
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scores enable benchmarking, describing the patient case-mix, and 
comparing various patient series as well as treatment facilities. 
Furthermore, these scores facilitate institutional quality control 
and resource allocation. Preoperative risk-assessment scores also 
provide objective information for patient-centered clinical decision 
making.  An international consensus on outcome-reporting criteria 
is a prerequisite for developing accurate risk-assessment scores.
A common belief is that neurosurgical patients’ preoperative phys-
ical status and comorbidities contribute to surgical outcome, but a 
reliable preoperative risk-assessment score is necessary to facilitate 
decision-making in cranial neurosurgery. The surgical outcome, how-
ever, should also be measured accurately and objectively. Currently, 
what	the	most	influential	studies	in	elective	cranial	neurosurgery	use,	
as	their	outcome	measure,	is	the	modified	Rankin	Scale	(mRS).16-20 
Like	the	ASA	score,	the	mRS	was	developed	for	a	completely	differ-
ent setting and has never been validated in neurosurgical patients. 
Reliable and objective risk assessment and outcome reporting are 
vital to optimizing resource allocation in neurosurgery, where the 
average patient age and the prevalence of age-related comorbidities 
is constantly increasing.21, 22
The current patient-centered focus of health care emphasizes the 
direct input and involvement of the patients in their own care. In 
concordance with this view, patient satisfaction ratings are increas-
ingly collected and even used for public outcome reporting and qual-
ity-of-care comparisons.23 Furthermore, measuring patient-reported 
outcomes (PROs) could promote openness and patient safety as well 
as minimize any subjectivity and inter-observer agreement issues 
associated with the conventional scoring systems.24-32 
The basis of this research project was a systematic review of the 
literature	on	preoperative	identification	of	craniotomy	patients	at	
high risk for unfavorable short-term surgical outcome. The aims of 
our prospective cohort study were to study the accuracy of preop-
erative risk-assessment methods, PROs and mRS as measures of 
surgical outcome, and also overall patient satisfaction in elective 
cranial neurosurgery.
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2. REVIEW OF THE LITERATURE
2.1 Preoperative evaluation of  
 elective craniotomy patients
2.1.1 Organization of preoperative evaluation
The organization of preoperative consultations varies considerably 
between countries and even within individual treatment centers. Most 
western neurosurgical centers arrange preoperative consultations 
with the operating surgeon and anesthesiologist as well as routine 
laboratory measurements and necessary radiological imaging stud-
ies. Some centers, aiming to optimize resource usage, have started 
preoperative clinics for outpatient consultations, whereas the more 
conventional approach is to arrange consultations with the surgeon 
and the anesthesiologist upon arrival in the hospital ward the day 
before scheduled surgery. During the last decade, the emergence 
of preoperative clinics has been catalyzed by the surge in same-day 
admissions. Quantifying the impact of arranging a preoperative clinic 
remains a challenge for researchers, but clearly, such clinics can 
facilitate	patient	flow	and	minimize	last-minute	cancellations.33 In 
many centers, the preoperative evaluation of neurosurgical patients 
follows the general preoperative evaluation scheme or department 
protocol,	but	specific	practice	guidelines	have	recently	appeared.34
2.1.2 Patient history
A treatment decision should always be based on assessment of the 
patient holistically. Health-care outcomes improve through paying 
attention to patient context.35 Patient-centered shared decision-mak-
ing integrates both evidence-based medicine and the individual 
patient’s values and preferences.36 In this process, patient history is 
a valuable tool for the surgeon in evaluating the general health status 
and current symptoms of the patient to determine which treatment 
options	are	justifiable	in	each	individual	case.	History	thus	plays	a	
crucial role even before the decision to operate. 
Patient history is also the basis of all anesthesiological preopera-
tive evaluations. Overall perioperative risk depends on the patient’s 
cardiorespiratory	fitness,	risks	associated	with	specific	illnesses	or	
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general health status, and risks associated with the planned surgical 
procedure. Estimating the patient’s cardiovascular capacity in Met-
abolic Equivalents (MET) gives vital information as to perioperative 
risk for cardiovascular complications or even mortality.37 A rough 
estimate can result from asking simple questions such as walking 
distance and ability to perform household chores. 
Many clinicians believe that knowledge of the patient’s chronic 
illnesses,	medications,	 and	 treatments	 is	 imperative	 for	 efficient	
preoperative	risk	modification	and	a	successful	anesthesia	plan.	To	
minimize risk for perioperative adverse events, all chronic illnesses 
and health risks including endocrine dysfunction,38 diabetes,39, 40 neu-
rologic diseases,41 heart conditions,42, 43 hypertension,44, 45 hyperthy-
roidism,46 renal failure,47-50 cirrhosis,51, 52 and alcohol abuse53 should 
be preoperatively in optimal balance. Thus, questions should aim at 
identifying ill-balanced chronic conditions. For example, a history 
of crescendo angina pectoris or poor glycemic control in a diabetic 
patient should raise concern and possibly lead to further diagnostic 
and therapeutic interventions in an attempt to stabilize the underly-
ing disease before proceeding with any scheduled elective surgery.37, 
54 Such interventions should always be carefully weighed against the 
possible risks associated with delaying any planned surgery. 
Additionally,	 illnesses	 and	 conditions	 affecting	 the	 choice	 of	
anesthetics or anesthesiological methods need careful assessment 
to guide in selection of the safest anesthesia modality for each in-
dividual patient. Accurate information on current medications is a 
cornerstone of successful preoperative assessment, because planning 
the perioperative medication is an integral part of every preoperative 
consultation.
Information about previous surgeries and anesthetics provides 
valuable	clues	to	possible	problems	such	as	difficult	airway	or	post-
operative nausea and vomiting (PONV). A preoperative health ques-
tionnaire helps in addressing these issues, and additional information 
is often available in hospital databases. 
Few	studies	exist	on	the	effect	of	preoperative	chronic	illnesses	
on	postoperative	outcome	in	the	specific	subgroup	of	neurosurgical	
patients. Elective cranial neurosurgery is considered major surgery, 
but results from studies with mixed patient groups undergoing ma-
jor surgery may not be directly applicable. At the very least, unique 
aspects inherent in elective cranial neurosurgery demand customized 
preoperative evaluations.  Special attention should be paid to the 
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intracranial process occurring. The location, nature, and size of the 
lesion may play a role in planning not only the surgery but also the 
anesthesia.	Due	to	the	complication	profile	associated	with	cranial	
neurosurgery, the risk for bleeding and thrombosis in patients on 
antiplatelet drugs or anticoagulants preoperatively should be noted. 
Discontinuation and re-introduction of such medications during the 
perioperative period demands careful planning. Furthermore, epilep-
sy may be a symptom of the intracranial process due to be resolved 
by surgery; although adequate preoperative antiepileptic medication 
is indicated, the cure is surgical.
2.1.3 Clinical evaluation
A meticulous clinical status is at the heart of preoperative surgical 
consultation. It enables the surgeon to gain information on functional 
deficits	and	symptoms	relevant	to	the	planned	operation.	It	also	pro-
vides the patient with the opportunity to bring forward any questions 
concerning treatment and outcome prognosis. The clinical evaluation 
is preferably conducted by the operating surgeon and serves for in-
dividual planning of the whole perioperative care process including 
surgical details such as positioning and approach.
A preoperative consultation with the anesthesiologist is a common 
routine for all patients undergoing major surgery, including elective 
craniotomy. Evidence as to the positive impact of such consultations 
on outcome is lacking, but the general view is that a clinical evalua-
tion	benefits	both	patient	and	anesthesiologist.	The	patient	receives	
information that helps alleviate anxiety associated with the upcoming 
surgery,	and	any	obscurities	can	be	clarified.55, 56 The anesthesiologist 
observes the patient’s general health status, assesses the airway, and 
makes focused clinical status assessments if any concerns arise. 
In	elective	neurosurgery,	neurological	symptoms	and	deficits	and	
clinical signs of elevated intracranial pressure (ICP) deserve special 
focus,	as	these	may	play	a	significant	role	in	planning	both	the	surgery	
and anesthetic.
Active individual encouragement to stop alcohol or substance 
abuse and cease smoking reduces perioperative risk, but for full 
benefit,	the	intervention	should	take	place	at	least	four	weeks	prior	to	
the planned surgery, before the preoperative clinical consultation.57-62 
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2.1.4 Laboratory measurements
In	the	absence	of	solid	scientific	evidence,	the	choice	and	extent	of	
preoperative laboratory measurements is usually based on expert 
opinions such as the guidelines of the National Institute for Health 
and Care Excellence (NICE) or the American Society of Anesthesiolo-
gists (ASA).63, 64 Screening tests are not a recommendation for healthy 
patients or patients whose chronic illness is in balance, especially 
preceding minor operations.63, 65 Treatment centers have protocols 
regarding	the	range	of	preoperative	laboratory	tests	in	specific	patient	
groups. For neurosurgical patients, preoperative laboratory tests 
identifying potential problems in blood coagulation or glycemic 
control (predisposition to infection) can be relevant to the compli-
cation	profile.		The	value	of	routine	prothrombin	time	measurements	
in elective neurosurgical patients with normal bleeding history is 
limited.66 Furthermore, activated partial thromboplastin time (aPTT) 
may be more accurate in predicting postoperative bleeding.67 All pre-
operative laboratory test choices should ideally be based on patient 
history,	clinical	findings,	and	risk	factors	associated	with	the	planned	
surgery, and all sets of routine laboratory measurements should be 
complemented by further tests according to individual needs. 
2.1.5 Radiological imaging
Awareness of the risks associated with radiation has reduced recom-
mendations for routine chest x-ray studies; these should be considered 
only if clinical signs indicate a potential condition that can be treated 
or	that	can	influence	surgical	outcome.63 
Radiological imaging facilitates a 
successful neurosurgical operative plan. 
Besides the exact size, location, and nature 
of the lesion, also the disturbance of normal 
anatomy, signs of elevated ICP and abnor-
malities	in	the	flow	of	cerebrospinal	fluid	
(CSF) are detectable. For intracranial tu-
mors, resonance imaging (MRI) is standard, 
but vascular lesions require angiography. 
Nowadays, conventional angiograms with 
x-ray are for the most part replaced by MRI 
angiograms with minimal radiation doses. 
Extra-axial tumor compressing the brain stem.                       
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2.2 Preoperative risk-prediction scores in surgery
2.2.1 Development of risk-prediction scores
Quantifying the risk involved in a surgical operation and anesthesia 
is a major clinical challenge. The need to communicate the per-
ceived risk to other professionals and even to the patient has led to 
development of several risk scores. Some scores, such as the ASA 
Physical	Status	Classification	score,7 are general and applicable to 
large patient populations across surgical specialties. Other scores 
predict	 the	 risk	 in	 very	 specific	patient	 subgroups,	 for	 example	
patients	undergoing	cardiac	surgery,	 in	an	effort	to	improve	the	
scores’	sensitivity	and	specificity.	Furthermore,	some	scores	aim	
at	predicting	specific	outcome	events	such	as	a	perioperative	myo-
cardial infarction (PMI).68, 69 Even scores originally developed for a 
completely	different	purpose	have	been	adopted	for	preoperative	
risk assessment.70, 71 
Generally, preoperative risk-assessment methods can be divided 
into two categories: risk scores and risk-prediction models.72 Most of 
the widely used methods are risk scores unable to provide individu-
alized prediction of risk for an unfavorable outcome.73
Developing a risk-prediction score requires large, methodological-
ly impeccable clinical studies and complex statistical skills combined 
with a sound clinical understanding of the interrelations between 
preoperative variables and postoperative outcomes. The importance 
of	correct	and	accurate	definitions	of	variables,	surgical	procedures,	
and outcomes is emphasized in the development of risk-prediction 
scores for very narrow patient subgoups.15
2.2.2 Challenges of risk prediction scores and  
 their implementation in clinical practice
Preoperative risk-prediction scores are useful supplemental tools for 
preoperative risk assessment; they cannot, however, replace the cli-
nician’s overall assessment and rarely incorporate a broader patient 
context.	Risk	scores	have	significant	limitations	of	which	the	clinician	
should be aware.
Score validation, or the lack thereof, is important to recognize. A 
score well documented for one patient group may not be applicable 
or	relevant	for	another.	As	with	any	treatment	or	medicine,	sufficient	
evidence is necessary before implementing a risk prediction score 
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in	clinical	use	for	a	specific	patient	group.	Unfortunately,	many	risk	
scores	have	been	generalized	despite	insufficient	validation	data.7, 32, 71 
The complexity of a score is a double-edged sword: Simple scores7, 
32 are widely applicable, whereas complicated risk scores are more 
difficult	to	implement	in	everyday	clinical	work.68, 74 However, the un-
derlying	reason	for	complexity	is	increased	specificity	and	sensitivity,	
as well as the score’s predictive value. Most often the score must be a 
compromise	between	these	two	conflicting	interests.
Inter-observer consistency is another major challenge for many 
scores used for preoperative risk prediction. The ASA physical status 
classification	and	the	modified	Rankin	Scale	are	both	subject	to	this	
phenomenon,	and	many	studies	have	addressed	its	effect	on	their	
reliability. 24-32
Some scores are based on purely preoperative factors and objec-
tive	findings.7, 32, 68, 71, 75 Others, such as the Physiological and Opera-
tive Severity Score for the enUmeration of Mortality and Morbidity 
(POSSUM), incorporate intra- or perioperative data. 
2.2.3 Example of customized risk prediction: The EuroScore
In	an	effort	to	improve	the	quality	of	cardiac	surgical	care,	the	Eu-
ropean system for cardiac operative risk evaluation (EuroSCORE) 
database served as a source for developing the EuroSCORE risk-strat-
ification	system	for	prediction	of	early	mortality	in	cardiac	surgical	
patients.14 The risk-score system, published in 1999, is based on 
objective risk factors for postoperative mortality. The reasons for 
developing	such	a	specific	risk	stratification	system	included	the	
need	to	couple	mortality	as	an	outcome	with	the	risk	profile	of	a	
hospital’s case mix. This coupling provides a risk-assessment tool for 
patient-centered shared decision-making, and promotes openness 
and benchmarking between care facilities.
 The original EuroSCORE is a complex scoring system with 19 
patient- and operation-related factors and their weighted scores. The 
risk is categorized as low, medium, or high, and mortality increases 
from 0.8% in the low-risk group to 11.2% in the high-risk group.14 
EuroSCORE predictive performance was, however, rated poor in one 
systematic review.76 
In 2012 an updated version (EuroSCORE II) replaced the original 
model. Its methodology was similar to that of the original score, but 
EuroSCORE	II	is	derived	from	a	more	current	dataset	which	reflects	
increased patient safety and decreased postoperative mortality.15 A 
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subsequent update project, EuroSCORE III, is underway.15 A recent 
meta-analysis	confirms	the	performance	of	the	EuroSCORE	II	model.77
Development of the EuroSCORE was possible due to a large da-
tabase with up-to-date, complete, and accurate perioperative data 
on cardiac surgery patients across Europe. Patients in the original 
developmental subset numbered over 13,000, and the score was 
validated in a subset of almost 1,500.14 The updated EuroSCORE II 
was derived from a dataset of almost 22,400 patients and validated 
in a subset of more than 5,500.
Despite its rather complex nature, the EuroSCORE has been 
widely and successfully implemented in clinical practice and even 
incorporated into hospital databases. 
Computed tomography angiography showing the Circle of Willis and an 
anterior communicating artery aneurysm.
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2.3 Proposed scales for preoperative  
 evaluation of elective craniotomy patients 
2.3.1 ASA Physical Status Classification
The	ASA	physical	status	classification	was	first	introduced	in	the	
1940’s and revised in 1963,6, 7 and is probably the most widely known 
and used model of preoperative risk-assessment scores. The current 
ASA	classification	comprises	six	categories,	ranging	from	healthy	
patients (ASA class 1) to severely ill patients likely to die within 24 
hours without surgery (ASA class 5) and even to brain-dead organ 
donors	(ASA	class	6).	The	current	ASA	classification	criteria	are	in	
Table 1. Since October 2014, ASA has provided examples to guide 
the	clinical	use	of	the	classification.8 The ASA physical status clas-
sification	is	a	brief	scale	and	easy	to	use	in	various	clinical	settings.	
The	ASA	 classification,	 despite	 its	 simplicity	 and	 familiarity	
among anesthesiologists, has received heavy criticism for its in-
ter-rater variability and dependence on the subjective views of the 
attending clinician.24-28	Furthermore,	various	modifications	of	the	
ASA	classification	exist.	Their	diversity	causes	difficulty	or	even	
makes	 it	 impossible	 to	 compare	 studies	 conducted	 in	 different	
institutions and countries. Along with the tremendous increase in 
standard	of	living	since	the	ASA	classification	was	first	introduced	
has come a change in the prevalence and incidence of many ill-
nesses.	The	classification	itself,	however,	has	remained	virtually	
unchanged.		The	limitations	of	the	classification	underwent	careful	
discussion in the original article by Saklad et al. in 1941.7 Modern 
anesthesiologists seem to have forgotten that its original purpose 
was	to	describe	the	physical	status	of	a	patient	with	one	classification	
for	scientific	and	statistical	purposes	–not	to	assess	the	anesthe-
siological or operative risk associated with a surgical procedure. 
Regardless of these shortcomings and the lack of validation, the 
ASA	classification	is	still	in	daily	clinical	use	in	neurosurgical	units	
worldwide, both for intracranial tumor surgery,75, 78-84 and for cere-
brovascular surgery.85 
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Table 1. The American Society of Anesthesiologists’ Physical Status Classification.7, 8
Description ASA score
A normal healthy patient 1
A patient with mild systemic disease 2
A patient with severe systemic disease 3
A patient with severe systemic disease that is a constant threat to life 4
A moribund patient not expected to survive without the operation 5
A declared brain dead patient whose organs are being removed for donor purposes 6
ASA, American Society of Anesthesiologists.
Adapted from “Evidence for the Use of Preoperative Risk Assessment Scores in Elective Cranial Neurosurgery: A 
Systematic Review of the Literature” by Reponen et al., Anesthesia & Analgesia August 2014 - Volume 119 - Issue 2 - 
p 420-32 (Study I). Printed with permission from Wolters Kluwer Health Lippincott Williams & Wilkins© 
2.3.2 Karnofsky Performance Score (KPS)
The KPS is originally a scale for the functional status of cancer pa-
tients.71 It has also served for surgical risk prediction, especially in 
neurosurgery. The score ranges from 0 (deceased) to 100 (normal 
healthy person with no signs of illness)(Table 2). In intracranial 
tumor surgery, the KPS is one of the most popular preoperative risk 
scores.86-89 In addition to patients with malignant tumors,81, 83, 90-93 it 
is routinely applied to those with intracranial meningioma.75, 78-80, 84, 94
Table 2. Karnofsky Performance  Score.71 
Description KPS score
Normal, no complaints, no evidence of disease 100
Able to carry on normal activity; minor signs or symptoms of disease 90
Normal activity with effort, some signs or symptoms of disease 80
Cares for self; unable to carry on normal activity or to do active work 70
Requires occasional assistance, but is able to care for most of his personal needs 60
Requires considerable assistance and frequent medical care 50
Disabled; requires special care and assistance 40
Severely disabled; hospital admission is indicated although death not imminent 30
Very sick; hospital admission necessary: active supportive treatment necessary 20
Moribund; fatal processes progressing rapidly 10
Dead 0
KPS, Karnofsky Performance Score
From “Evidence for the Use of Preoperative Risk Assessment Scores in Elective Cranial Neurosurgery: A Systematic 
Review of the Literature” by Reponen et al., Anesthesia & Analgesia August 2014 - Volume 119 - Issue 2 - p 420-32 
(Study I). Printed with permission from Wolters Kluwer Health Lippincott Williams & Wilkins©
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2.3.3 mRS score
In the 1950’s, Dr. John Rankin developed a score for assessing the 
outcome of stroke patients.70	This	was	later	modified	for	the	United	
Kingdom transient ischaemic attack (UK-TIA) aspirin study,95 and 
the	modified	version	was	validated	by	Van	Swieten	et	al.	in	1988.32 
The mRS score ranges from 0 (no symptoms) to 6 (dead) (Table 3). At 
scores 0 to 2 patients are functionally independent, whereas at scores 
3 and higher patients are dependent on other’s aid in everyday activ-
ities. In cranial neurosurgery, the mRS often serves for preoperative 
risk prediction in cerebrovascular surgery patients.96, 97
Table 3. Modified Rankin Scale.32, 70
Description mRS score
No symptoms 0
No significant disability. Able to carry out all usual activities, despite some 
symptoms
1
Slight disability. Able to look after own affairs without assistance, but unable  
to carry out all previous activities
2
Moderate disability. Requires some help but able to walk unassisted 3
Moderately severe disability. Unable to attend to own bodily needs without 
assistance and unable to walk unassisted
4
Severe disability. Requires constant nursing care and attention, bedridden, 
incontinent
5
Dead 6
mRS, modified Rankin Scale. 
From “Evidence for the Use of Preoperative Risk Assessment Scores in Elective Cranial Neurosurgery: A Systematic 
Review of the Literature” by Reponen et al., Anesthesia & Analgesia August 2014 - Volume 119 - Issue 2 - p 420-32 
(Study I). Printed with permission from Wolters Kluwer Health Lippincott Williams & Wilkins©
2.3.4 Charlson comorbidity score 
The Charlson Comorbidity Score is a weighted index that takes into 
account the severity of a patient’s comorbidities. It was originally 
developed as a prospectively applicable method for classifying comor-
bid conditions which might alter the risk of mortality in longitudinal 
studies.98 A total of 22 comorbidities are considered in this score, each 
one assigned a weighted score of 1, 2, 3, or 6. The sum of the scores 
represents the patient’s overall comorbidity. The Charlson Comorbid-
ity Index is a later version of the score in which every decade of age 
over 40 raises the total score by 1. In short, the higher the score, the 
higher the risk of adverse outcome after surgery. Weighted scores for 
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various comorbidities according to the Charlson comorbidity score 
are in Table 4. The Charlson comorbidity score has been applied 
in	the	preoperative	risk	stratification	for	patients	with	intracranial	
tumors99, 100 and with unruptured intracranial aneurysms.101
Table 4. Charlson Comorbidity Score.98
Conditions Score
Myocardial infraction (history, not ECG-changes only)
Congestive heart failure
Peripheral vascular disease (includes aortic aneurysm  ≥6 cm)
Cerebrovascular disease: CVA with mild or no residua or TIA
Dementia
Chronic pulmonary disease
Peptic ulcer disease
Mild liver disease (without portal hypertension, includes chronic hepatitis)
Diabetes without end-organ damage (retinopathy, neuropathy, nephropathy, or 
brittle diabetes)
1
Hemiplegia
Moderate or severe renal disease
Tumor without metastases (exclude if >5 years from diagnosis)
Leukemia (acute or chronic)
Lymphoma
2
Moderate or severe liver disease 3
Metastatic solid tumor
AIDS (not just HIV-positive)
6
For each decade >40 years of age, a score of 1 is added to the above score to yield the total Charlson Comorbidity 
Index score.
AIDS, acquired immunodeficiency syndrome; CVA, cerebrovascular disease; ECG, electrocardiogram; HIV, human 
immunodeficiency virus; TIA, transient ischemic attack.
From“Evidence for the Use of Preoperative Risk Assessment Scores in Elective Cranial Neurosurgery: A Systematic 
Review of the Literature” by Reponen et al., Anesthesia & Analgesia August 2014 - Volume 119 - Issue 2 - p 420-32 
(Study I). Printed with permission from Wolters Kluwer Health Lippincott Williams & Wilkins©
2.3.5 SKALE score
A proposed risk-assessment system for meningioma patients called 
the Sex, Karnofsky, ASA, Location, and Edema (SKALE) score com-
prises	five	independent	factors:	sex,	KPS,	ASA	classification,	menin-
gioma location, and peritumoral edema.75 Each factor earns 0, 2, or 
4 points, and a low total score suggests an unfavorable neurological 
outcome (Table 5). The SKALE score is applicable only to intracranial 
meningioma patients.75, 84
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Table 5. The Sex, Karnofsky Performance Score, American Society of Anesthesiologists 
Class, Location of tumor, and Peritumoral Edema (SKALE) Grading System.75
Score
Factors 0 2 4
Sex M F -
KPS ≤50 60-70 ≥80
ASA class IV III I or II
Location Critical Not critical -
Edema Severe Moderate No edema
ASA, American Society of Anesthesiologists; F, female; KPS, Karnofsky Performance Score; M, male.
From “Evidence for the Use of Preoperative Risk Assessment Scores in Elective Cranial Neurosurgery: A Systematic 
Review of the Literature” by Reponen et al., Anesthesia & Analgesia August 2014 - Volume 119 - Issue 2 - p 420-32 
(Study I). Printed with permission from Wolters Kluwer Health Lippincott Williams & Wilkins©
2.3.6 Other scores
2.3.6.1 POSSUM and P-POSSUM
POSSUM	and	its	modified	version	P-POSSUM	(Portsmouth	Physio-
logical and Operative Severity Score for the enUmeration of Mortality 
and Morbidity) are complex risk-prediction models.102, 103 A recent 
systematic	 review	on	 risk	 stratification	 tools	 for	noncardiac	 and	
nonneurological surgical patients supported the use of P-POSSUM 
for predicting morbidity and mortality.72 POSSUM and P-POSSUM 
can	provide	individualized	prognostic	figures	and	have	been	applied	
to neurosurgical patients in a few studies, but require estimation of 
intraoperative factors such as blood loss. Due to their complexity, the 
POSSUM scores are not easily applicable in a clinical context and lack 
validation for use in cranial neurosurgery.
2.3.6.2 ECOG Performance Status
The Eastern Cooperative Oncology Group (ECOG) has published a 
performance status score with the aim of assessing how the patient’s 
disease	is	progressing,	assessing	how	the	disease	affects	daily	life,	and	
determining appropriate treatment and prognosis.104 It is a six-tier 
score in which zero represents a fully active and capable individual, 
three represents a patient dependent on the help of others, and 5 rep-
resents those deceased. This scale was originally developed for onco-
logical patients, but has not been extensively applied to patients with 
brain tumors. Thus, its applicability to an unselected cohort of elective 
craniotomy patients remains unsupported by current evidence. 
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2.4 Scales measuring cognitive function
2.4.1 MMSE 
The mini-mental state examination (MMSE) is the gold standard in 
assessing a patient’s cognitive status and memory. Folstein et al. in-
troduced	the	original	test	in	1975	with	the	aim	to	differentiate	organic	
from functional psychiatric patients.105 Comprising 30 questions, the 
test is relatively short and can be completed within the time con-
straints of a normal outpatient visit at a health-care center or hospital 
outpatient clinic. The questions in the MMSE involve knowledge of 
time and place, repetition of word lists, arithmetic, language use and 
comprehension and basic motor skills. The maximum score is 30, 
and	any	score	≥27	points	indicates	normal	cognitive	status.	Cognitive	
impairment is categorized as severe (0-17) or mild (18-24 points). 
The MMSE is most valuable as a screening device or a diagnostic 
adjunct.
The major advantages of the MMSE include its validity and reli-
ability for the diagnosis and longitudinal assessment of Alzheimer’s 
disease, and its feasibility in clinical practice because of its ease of use 
and brevity. The test, however, has some considerable disadvantages, 
including	its	being	affected	by	factors	such	as	age	or	educational	
attainment. Physical problems, poor vision, and hearing loss can 
interfere with interpretation if not properly addressed. Furthermore, 
the MMSE lacks sensitivity to identify mild cognitive impairment 
and progressive changes occurring with severe Alzheimer’s disease.
The MMSE test requires a trained administrator who observes the 
patient,	asks	the	specified	questions,	records	the	answers,	and	finally,	
after the completion of the test, calculates the total score. Thus, the 
test	cannot	be	filled	in	by	the	patient	alone,	and	the	use	of	the	MMSE	
test in a study setting requires substantial personnel resourcing.
2.4.2 Test Your Memory (TYM) 
The	TYM	tool	was	developed	to	fulfill	three	criteria	that	other	cog-
nitive tests fail to meet. It was designed to require minimal operator 
time to administer, to test a reasonable range of cognitive functions, 
and to be sensitive to mild Alzheimer’s disease.106The time criterion 
was achieved by design of the test to be self-administered, unlike 
the MMSE, without any need for a trained administrator. Average 
time for test completion has been reported at 5 minutes.106 The TYM 
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consists of 10 questions, and the maximum score is 50 points. In the 
original	validation	study,	a	TYM	score	≤44	points	detected	96%	of	
patients with mild Alzheimer’s, and a score of 45 points or higher 
thus implies normal cognitive status. 
The TYM may have several advantages over other tests of cognitive 
dysfunction. It is brief, yet not too limited for grading the severity of 
any cognitive impairment. The reasonably wide range of scores in the 
TYM test allows for better discrimination and improves its suitability 
for monitoring. Inter-rater agreement for scoring is excellent due to 
its strict scoring system.106	The	test	provider	has	minimal	influence	
over	the	score,	because	the	patients	fill	in	the	test	themselves.	
2.5 Outcome of elective craniotomy patients 
2.5.1 Short-term morbidity and mortality 
Short-term	morbidity	and	mortality	are	usually	defined	in	neuro-
surgery as the immediate postoperative period of up to 30 days. 
Morbidity associated with elective cranial neurosurgery comprises 
two distinct categories: systemic or infectious complications and 
surgery-related (neurological) complications. The former are similar 
to those from other types of major surgery: cardiovascular compli-
cations such as PMI or heart failure, infections such as pneumonia 
or sepsis, and thromboembolic complications such as pulmonary 
embolism (PE) or deep venous thromboembolism (DVT). The sur-
gery-related	complications	reflect	the	delicate	operative	field	and	
often have a major impact on postoperative functional status: new or 
worsened hemiparesis, postoperative hemorrhage or stroke, cranial 
nerve lesions, meningitis, and CSF leakage. Furthermore, elective 
craniotomy patients are prone to minor complications, much like 
any surgical patient. These include minor infections such as urinary 
tract infection (UTI) and postoperative wound infections (WIs). In 
modern elective neurosurgery, even cosmetic outcome is considered 
important, and techniques ensuring minimal visual scars or other 
permanent defects are desirable.107
Mortality is a crude outcome measure, but still often serves in 
evaluating and measuring the quality of health care, including 
neurosurgery. Many factors appear to impact mortality rates in 
neurosurgical patients; this has led to harsh criticism against use of 
mortality rates or mortality indices for outcome comparisons between 
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treatment centers.108 In modern neurosurgery, expected mortality 
rates in western neurosurgical units are low.109 A trend toward in-
creasing mortality in neurosurgical patients has appeared in hospitals 
with a lower percentage of elective neurosurgical cases, in Level 1 
trauma	centers,	and	in	hospitals	not	certified	as	stroke	centers.	This	
trend,	however,	fails	to	reach	statistical	significance.108 During the 
past two decades, age has ceased to be a contraindication for cranial 
neurosurgery, and mortality rates even in the elderly have dropped.110
Prospective outcome reports for unselected elective craniotomy 
patients are lacking. A recent large retrospective cohort of over 16,000 
patients undergoing elective or emergent neurosurgical procedures 
came out of the American College of Surgeons (ACS) National Sur-
gical Quality Improvement Program (NSQIP) database. It showed 
the rate of postoperative morbidity to be 15.8% and mortality 1.6% at 
30 days.109 Furthermore, the rate of postoperative morbidity (20.1%) 
and mortality (2.1%) was considerably higher if a resident was the 
operating surgeon together with an attending, whereas patients with 
an	attending	as	the	only	operating	surgeon	had	significantly	lower	
morbidity (11.7%) and mortality (1.6%) rates at 30 days (p<0.001 for 
both morbidity and mortality).109 It should be noted, however, that 
both elective and emergency patients were included in the analyses; 
both cranial and spinal neurosurgical procedures were retrieved from 
the	database,	and	thus	these	numbers	cannot	reliably	reflect	the	short-
term morbidity and mortality rates for elective cranial neurosurgery. 
In a large, retrospective analysis of administrative data for 34,256 
surgical patients treated during 2010 in 12 hospitals in the United 
States, patients undergoing intracranial procedures had the highest 
complication rates at discharge: 17.1%.111 Furthermore, a retrospec-
tive analysis of over 10,000 cranial neurosurgical patients in 400 
hospitals	identified	by	means	of	Current	Procedural	Terminology	
(CPT) codes from the ACS NSQIP database reported a complication 
rate of 23.6%.112 The American Association of Neurological Surgeons’ 
(AANS) National Neurosurgery Quality and Outcomes Database 
launched in March, 2012, relies on prospectively collected outcomes 
data, and a module for patients undergoing intracranial surgery is 
expected to be implemented in the near future.113 
Comparison	of	reported	short-term	morbidity	figures	in	cranial	
neurosurgical	patients	is	hampered	by	diverse	definitions	of	mor-
bidity; this is evident in the wide range of morbidity and mortality 
rates across studies. Outcome reports for unselected series of elec-
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tive craniotomy patients are lacking, numbering only two reports 
with	very	narrow	definitions	for	morbidity.	According	to	these	two	
studies, morbidity rates were 5.5% to 7.7%,114, 115 and mortality rates 
7.3% to 8.0%.114 In patients with malignant tumors, reported short-
term morbidity rates range from 15.0% to 35.0% and short-term 
mortality rates from 1.5% to 3.0%.81, 83, 90-93 For patients with benign 
tumors, short-term morbidity rates range from 42.7% to 60.0%,82, 94 
whereas short-term mortality rates range from 0.0% to 23.0%.75, 80, 
82, 94		Studies	on	patients	with	unspecified	intracranial	tumors	report	
short-term morbidity rates from 3.0% to 41.7%,86-89 and short-term 
mortality rates from 1.2% to 3.6%.86, 88, 89 In intracranial vascular sur-
gery patients, short-term morbidity rates range from 8.4% to 56.0%97, 
101 and short-term mortality of 1.6%.101 
2.5.2 Long-term morbidity and mortality 
In contrast to short-term morbidity, the underlying diagnosis or 
disease has a greater impact on long-term morbidity and mortality. 
Long-term	(≥6	months)	outcome	for	patients	with	malignant	tumors,	
for example, is for the large part determined by progression, location, 
and histological type of malignancy. 
No long-term data on unselected series of elective craniotomy 
patients have appeared. A retrospective study on 4907 patients 
with metastatic brain tumors reported a long-term morbidity rate 
of 8.9% and long-term mortality rate of 4.0%.99 For patients with 
benign tumors, the reported long-term morbidity rates range from 
9.4% to 21.0%,75, 84, 94, 100 and long-term mortality rates from 3.2% to 
16.7%.75, 78-80, 82, 84, 100 In patients undergoing craniotomy  for vascular 
indications, long-term morbidity rates range from 14.9% to 16.5%,85, 
96 and long-term mortality rates from 0.0% to 5.0%.85, 96, 97 
2.5.3 The mRS as a proxy for surgical outcome
Neurosurgical units worldwide have adopted the mRS as a proxy for 
surgical outcome, even though the original purpose of the mRS was to 
measure functional outcome in patients recovering from spontaneous 
stroke.70 The mRS serves as a measure of outcome not only in clinical 
work but also for research purposes, both in cranial tumor surgery116-118 
and in cerebrovascular surgery,119-129	including	the	most	influential	
studies	in	the	field.16-18, 20 Evidence for the validation of the mRS as 
a surrogate outcome measure in neurosurgery is, however, lacking.
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2.5.4 Quality of life 
Quality of life (QOL) following elective cranial neurosurgery is mainly 
determined	by	the	patients’	postoperative	neurological	deficits.	Postop-
erative systemic and infectious complications, however, can also exert 
a	deleterious	effect	on	functional	recovery.	A	prolonged	need	for	pain	
medication or corticosteroids or both, along with depression, has re-
portedly lowered postoperative QOL in patients with skull-base chor-
domas.130 In patients with malignant intracranial tumors, adjuvant ther-
apies such as whole-brain radiotherapy or local radiation therapy may 
have a profound impact on quality of life.131, 132 In a recent prospective 
study on 180 Italian patients scheduled for neurosurgical operations, 
the European Health Interview Survey -Quality of Life (EUROHIS-QOL) 
8-item index was useful as a quality-of-life measurement technique.133
2.5.5 Patient-reported outcomes (PROs) and  
 patient-reported outcome measures (PROMs)
PROs are tools for implementing a patient-centered focus on outcome 
reporting in health care. The US Food and Drug Administration de-
fines	a	PRO	as	“a	report	that	comes	directly	from	the	patient	about	
the status of a patient’s health condition without amendment or in-
terpretation of the patient’s response by a clinician or anyone else.”134 
Current focus on quality of care and public outcome reporting has 
made	PROs	a	hot	topic	across	the	field	of	health	care	in	recent	years.	
In a very recent study on intracranial tumor patients, PROs were more 
sensitive than hospital records in identifying postoperative new or 
worsened	neurological	deficits.135
PROMs	are	either	generic	or	disease-specific	validated	tools	or	
instruments for reporting PROs.136 It is important to distinguish 
PROMs from patient-reported experience measures (PREMs) such as 
structured patient-satisfaction questionnaires which focus on the pa-
tient’s experience and the humaneness of care rather than on physical 
symptoms and health-related quality of life.136 PROMs are often in the 
form of self-completed questionnaires,137 so the response rate plays an 
important role in credibility. Modern web-based surveys provide easy 
access and real-time availability of data,138 but conventional paper 
questionnaires may achieve better response rates.139
PROMs aim at improving patient safety and can guide clinicians 
and	hospitals	in	decision-making.	PROMs	also	benefit	patients	by	
enabling comparisons between hospitals, thus facilitating treatment 
choices. The implementation of PROMs in patient-centered outcomes 
research (PCOR) and clinical practice has been led by primary care 
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and	psychiatry,	with	the	clearest	benefits	emerging	in	the	diagnosis	
of depression.136 Other specialties, including surgery, have gradually 
adopted PROMs as tools for research and quality-improvement 
initiatives.	Both	disease-specific	and	generic	PROMs	are	 routine	
in outcome-reporting for hip and knee surgery.140 Recently, the 
applicability of two PROMs, the 12-item World Health Organization 
Disability Assessment Schedule (WHODAS-12) and the 8-item EU-
ROHIS-QOL, in an unselected cohort of 180 Italian neurosurgical 
patients has been reported in two articles by Schiavolin and cowork-
ers.133, 141	They	were	able	to	confirm	the	factor	structure	and	validity	
of these PROMs, and their conclusions could support the use of these 
PROMs in neurosurgery departments.
Routine implementation of PROMs has proven successful in Swe-
den with its national quality registers since 1975.142, 143 Since 2009, 
a mandatory audit of all providers of hip- and knee-replacement, 
varicose-vein surgery, and groin-hernia repair in England has ac-
cumulated comprehensive PROMs data.144 Such data can serve to 
improve care in three ways: assisting clinicians to provide better 
and more patient-centered care, assessing and comparing provider 
quality, and providing data for evaluating practices and policies.136 
2.5.6 Patient satisfaction
In the era of patient-centered health care, institutions and care-pro-
viders are undertaking surveys of patient satisfaction at an increasing 
rate. In the United States, the Centers for Medicare and Medicaid 
Services announced a new reimbursement method in 2011 based on 
patient satisfaction.23 Patient satisfaction scores are publicly displayed 
online to enable open comparison between treatment centers in New 
South Wales, Australia.145 Due to its being feasibly collectable, patient 
satisfaction has emerged as a popular proxy for quality of care. It is, 
however, important to distinguish between patient experience and 
treatment outcomes and not to confuse methods of measuring each 
dimension of health care quality.146 High-quality care and good patient 
satisfaction can be achieved simultaneously,147, 148 but their direct 
correlation has been questioned.149 In surgical patients, poor satis-
faction is commonly believed to represent poor-quality care. Overall 
satisfaction has not, however, proved a reliable measure of quality 
of care.150-152 In spine surgery patients, patient satisfaction is a poor 
surrogate	either	for	the	quality	or	the	effectiveness	of	care.153 Overall 
satisfaction ratings in large register-based studies in surgical patient 
are high,147, 149	but	specific	figures	for	cranial	neurosurgery	are	lacking.
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3. AIMS OF THE PRESENT STUDY
The objective of the present study was to evaluate preoperative 
risk-assessment methods, short-term outcomes, and patient satis-
faction in elective cranial neurosurgery.
The	specific	aims	of	this	study	were	to	determine	the
1. current state of knowledge as to the use of preoperative risk-as-
sessment scores for elective craniotomy patients (I)
2. short-term complication types and rates after elective cranial 
neurosurgery (II, III, IV)
3. applicability of variables and scores currently in use for preoper-
ative risk prediction in elective craniotomy cranial neurosurgery 
(II)
4. reliability of patient-reported outcomes and mRS in outcome 
reporting  after elective craniotomy (III, V)
5. overall satisfaction of elective craniotomy patients and correla-
tions between patient experience and short-term outcome (IV).
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4. PATIENTS AND METHODS
4.1 Methods of the systematic review (I)
Study I was a qualitative systematic review of the current evidence 
in the literature on the use of preoperative risk-assessment scores 
in elective cranial neurosurgery. MEDLINE, Embase, and Pubmed 
databases served for identifying English-language articles published 
between January 1, 1980 and November 14, 2013. The initial search 
yielded 2229 articles, of which 128 reported original data for at 
least 30 patients and were selected for full-text review. Articles 
were excluded if they reported survival as the only outcome, they 
included only emergency operations, used scales with intraoperative 
variables, or reported less than 24-hour follow-up periods. Due to 
possible publication bias, in cases in which only one eligible study 
reported	on	a	specific	preoperative	risk-assessment	score,	that	study	
was excluded (9 studies). Furthermore, no reviews and commentar-
ies	were	included	in	Study	I.	The	final	number	of	studies	in	Study	
I was 25. Study I followed the PRISMA guidelines for systematic 
reviews. Due to the extreme heterogeneity of the studies, quantitative 
analyses (meta-analyses) were impossible.
4.2 Patients (II-V)
Helsinki	University	Hospital	 is	 a	public	non-profit	organization	
with 22,000 employees providing tertiary health-care services 
for 1.6 million people in the Helsinki area. With over 1.6 million 
outpatient visits and 90,000 surgeries each year, it is the second 
largest hospital organization in the western world. Its Department 
of Neurosurgery, famous for its cerebrovascular surgery, is among 
the largest neurosurgical centers in western countries with 3,600 
surgeries annually, 18 to 19 specialist neurosurgeons, 5 operating 
rooms, and 250 employees.
A total of 644 patients underwent craniotomy surgery in the 
Department of Neurosurgery in Helsinki University hospital during 
the study enrollment period between 7 December, 2011 and 31 De-
cember, 2012. Informed consent was obtained from 419 patients, 
while 226 were either excluded (93), not reached preoperatively (85), 
or withheld consent to participate (47). One patient withdrew her 
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informed consent before the study ended. The exclusion criteria are 
summarized	in	Table	6.	The	final	number	of	participants	was	418,	
75.9%	of	those	eligible.	The	study	flow-chart	is	presented	in	Figure	1.	
An	elective	operation	was	defined	as	a	scheduled	operation	for	which	
the decision to operate was made at least 7 days prior to surgery. For 
Patient characteristics in all patients and in indication subgroups see 
Table	7.	To	our	knowledge,	this	is	the	first	study	on	an	unselected,	
prospective cohort of elective craniotomy patients.
Table 6. Study exclusion criteria  
Number of 
patients
Age under 18 years 33
Inability to communicate due to severe illness or advanced cognitive dysfunction 11
Non-fluency in Finnish or Swedish 34
Craniotomy for epilepsy (implantations of electrode grids for electro-
corticographic recordings and/or subsequent resections of epileptogenic zones)
10*
Previous enrollment in study 11
* 6 patients also under 18 years old
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Adapted from “Preoperative identification of neurosurgery patients with a high risk of in-hospital 
complications: a prospective cohort of 418 consecutive elective craniotomy patients” by Reponen et al., 
Journal of Neurosurgery: September 2015 – Volume 123 – Issue 3 – p 594-604 (Study II). Printed with 
permission from the American Association of Neurological Surgeons©.
Figure 1. Study flow-chart. 
644 elective craniotomy patients  
between 7 Dec, 2011 and 31 Dec, 2012
551 potential study patients
Total excluded (93)
No preoperative informed consent (85) 
Patient refused informed consent (47)
Withdrew informed consent before  
study completion (1)
226 elective craniotomy patients  
not enrolled
419 patients enrolled
418 study patients
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4.3 Methods (II-V)
4.3.1 Study design 
The study design was prospective, observational, and aimed at 
collection of an unselected cohort of patients undergoing elective 
craniotomy in the Department of Neurosurgery, Helsinki University 
Hospital,	Helsinki,	Finland.	Participation	in	the	study	did	not	affect	
the preoperative, intraoperative or postoperative care, all of which 
adhered to the department’s standard treatment protocols.
4.3.2 Study protocol and data collection
All patients scheduled for an elective craniotomy either visited the 
preoperative outpatient clinic (243 patients, 58.1%) for preoperative 
surgical and anesthesiological evaluation or were admitted in the 
neurosurgical ward (175 patients, 41.9%) the day before surgery for 
preoperative evaluations. Patients received verbal and written infor-
mation about the study after which they gave their informed consent. 
Patients agreeing to participate completed the preoperative forms 
at this stage. Preoperative laboratory testing (Table 8) and clinical 
evaluation, including measurement of systolic blood pressure (SBP), 
diastolic blood pressure (DBP), and heart rate (HR), adhered to the 
department’s standard practice. Additional tests were performed if 
considered appropriate by the evaluating anesthesiologist or surgeon. 
Table 8. Routine preoperative laboratory tests for elective craniotomy patients
Blood count blood hemoglobin (Hb), g/l
blood hematocrit (Hcr), %
blood erythrocyte count, E12/l
erythrocyte mean cell volume (MCV), fl
erythrocyte mean cell Hb (MCH), pg/cell
erythrocyte mean cell Hb concentration (MCHC), g/l
blood leucocyte count, E9/l
blood platelet count, E9/l
Electrolytes plasma potassium (K), mmol/l
plasma sodium (Na), mmol/l
Renal function plasma creatinine (Crea), µmol/l
Infection plasma C-reactive protein (CRP), mg/l
Glucose plasma glucose (Gluc) not fasting, mmol/l
Coagulation plasma prothrombin time (PT), %
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The patients received detailed information on continuing or discon-
tinuing their normal medications prior to the surgery. In particular, 
patients received routine instructions for the discontinuation of 
anticoagulant or antithrombotic medications unless there was a com-
pelling reason to proceed with the surgery even if discontinuation of 
such medication was impossible. Warfarin is routinely discontinued 
5 days prior to elective craniotomy at our institution.  If the indication 
for	warfarin	is	other	than	sole	atrial	fibrillation,	or	the	atrial	fibrilla-
tion is complicated by other problems such as cardiac failure, a low 
molecular weight heparin (LMWH) is substituted during warfarin 
discontinuation. 
At our institution, for patients on continuous acetosalicylic acid 
medication, and whose circulatory status allows, acetosalicylic acid 
is discontinued for at least 5 days prior to the elective craniotomy. If 
the patient’s circulatory status does not allow for discontinuation of 
acetosalicylic acid, indications for elective craniotomy are reviewed, 
and timing carefully reconsidered; surgery may be postponed until 
acetosalicylic acid can be safely discontinued. The assessing anes-
thesiologist gives instructions on discontinuation of other types of 
anticoagulant or antithrombotic medication on an individual case-
by-case basis.
Study personnel collecting all data were separate from the clinical 
staff.	Preoperative	data	were	available	from	a	preoperative	ques-
tionnaire (Appendix 1) and from a preoperative TYM questionnaire. 
One of the study anesthesiologists or a study nurse completed a 
preoperative study form. Perioperative data were collected manually 
from the operating room and laboratory databases as well as from 
hospital patient records. Postoperative data were collected through 
a patient-completed questionnaire (Appendix 2), and a second 
TYM questionnaire identical to the one preoperatively. One of the 
study anesthesiologists completed a postoperative study form at 
discharge. One study anesthesiologist conducted a structured tele-
phone interview to record postoperative outcome data and patient 
satisfaction at 30 days after surgery.  The information obtained was 
supplemented when necessary with patient information derived from 
hospital patient records and clinical information systems. All data 
were then manually transferred to International Business Machines 
(IBM®) Software Package for Statistics and Simulation (SPSS®) 21.0 
statistical software for statistical analysis.
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4.3.3 Preoperative variables and scores 
Preoperatively collected information included patient character-
istics (sex, age, height, and weight), Body Mass Index (BMI), and 
preoperative living arrangements (home, assisted residency, nursing 
home, health-care center, or hospital). Patients reported the health 
conditions listed in Table 9 (yes/no; diagnosis and when diagnosed)
Table 9. Preoperative health conditions.
Condition
Patients (%)
N=417
Heart condition 44 (10.6)
Arrhythmia 54 (12.9)
Dyspnea 38 (9.1)
Chronic lung illness 51(12.2)
Atherosclerosis, carotid artery stenosis, claudication 7 (1.7)
Deep vein thrombosis, pulmonary embolism, thrombogenic condition 20 (4.8)
Stroke, intracranial hemorrhage 61 (14.6)
Cancer 125 (30.0)
Diabetes mellitus* 47 (11.3)
Epilepsy 84 (20.1)
*N=415
Questions on health-related habits were adapted from the Health 
2000  survey of the National Public Health Institution in Finland.154 
Selected questions covered smoking (number of cigarettes per day, 
smoking years, when ceased) and alcohol consumption (none, 
moderate, excessive) within the past 7 days. Moderate alcohol con-
sumption	was	defined	as	1	to	16	doses	for	women	and	1	to	24	doses	
for men. Alcohol consumption exceeding 16 doses (women) and 24 
doses (men) was categorized as excessive. Patients reported their 
preoperative average frequency of physical exercise (duration at least 
20	minutes,	sufficiently	intensive	to	cause	shortness	of	breath)	on	a	
5-tier scale: none (unable due to illness or physical condition), less 
often than once a week, once a week, 2 to 3 times a week, or 4 times a 
week or more. Stair-climbing served as a measure of cardiorespirato-
ry	fitness.155	A	flight	of	stairs	was	defined	as	a	vertical	climb	between	
two	floors	(at	least	4	meters),	and	patients	reported	whether	they	
could	climb	two	flights	of	stairs	without	resting,	and	if	not,	why.	Fur-
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thermore, patients categorized their preoperative subjective overall 
health	status	and	physical	fitness	as	excellent,	good,	average,	poor	
or very poor. The detailed questions are in Appendix 1. Additionally, 
the patients completed the TYM questionnaire preoperatively.
At the time of the preoperative consultation, the neuroanesthe-
siologist recorded data on date of operation, place of preoperative 
consultation and basic patient characteristics. Other recorded vari-
ables	included	medications	affecting	blood	coagulation	(acetosali-
cylic acid, dipyridamole, warfarin, LMWHs, clopidogrel, novel oral 
anticoagulants including dabigatran and rivaroxaban), preoperative 
blood pressure, heart rate, laboratory measurements (Table 8), and 
possible preoperative neurological symptoms.
Preoperative scores included the Charlson comorbidity score, 
original	ASA	classification	score	(Table	1),	preoperative	mRS	score	
(Table	3),	and	the	modified	Helsinki	ASA	classification	score	in	clini-
cal use in the Department of Neurosurgery, Helsinki University Hos-
pital, since the mid 1990’s (Table 10). Other preoperatively recorded 
variables comprised location of the craniotomy (supratentorial or 
infratentorial), indication for surgery (malignant tumor, benign tu-
mor, vascular indication, or other indication), and experience of the 
operating surgeon and of the attending anesthesiologist (specialist/
resident).
Table 10. Helsinki ASA classification
Helsinki 
ASA score Description
1 Previously healthy patient, age <65 years
2 Previously healthy patient, age ≥65 years
Patient with mild systemic disease
3 Patient with severe systemic disease
Previously healthy patient <65 years, with a small unruptured intracranial 
aneurysm or a small brain tumor with no symptoms/mild symptoms
4 Patient with unbalanced systemic disease
Previously healthy patient with a clearly symptomatic intracranial aneurysm 
or brain tumor
5 Moribund patient not expected to survive without emergency surgery
44
Patients and methods
4.3.4 Perioperative variables 
The data collected also included perioperative variables. Duration of 
anesthesia and surgery (in minutes) came from the operating room 
database along with information concerning patient positioning 
during surgery (supine, prone, lateral park bench, sitting, or other 
position), intraoperative blood loss, time of extubation [in the oper-
ating room, in the intensive care unit (ICU) postoperatively <6 hours, 
or	≥6	hours]	and	choice	of	anesthetic	(propofol,	volatile	anesthetic,	
or both, and whether also nitrous oxide was used). 
4.3.5 Postoperative in-hospital variables and scores 
The recorded postoperative variables and scores included date of 
discharge from the hospital (length of stay), and place discharged to 
(home, assisted living, nursing home, health-care center, or hospital). 
Patients were invited to report any postoperative neurological symp-
toms	or	deficits	and	were	specifically	asked	about	new	or	worsened	
hemiparesis,	subjective	visual	disturbances	(SVD),	speaking	difficul-
ties (dysphasia, dysarthria), dysphagia, local WI or asymptomatic 
meningitis, other infections, stroke or cerebral ischemia, pneumonia, 
thromboembolic complications (PE, DVT) and heart attack (Appen-
dix 2). 
Furthermore, the patients reported whether their subjective func-
tional status had changed during hospitalization (better, unchanged, 
or worse). The postoperative TYM score and the mRS score assigned 
by a study anesthesiologist were recorded at hospital discharge. 
Length of ICU stay in days as well as blood hemoglobin (Hb) con-
centration	on	the	first	postoperative	morning	were	recorded,	together	
with possible reoperations and prolonged problems of ventilation or 
dysphagia necessitating tracheostomy. An anesthesiologist also re-
corded possible complications and neurological symptoms at hospital 
discharge. The rate of in-hospital mortality was available from the 
Population Register Center of Finland and from hospital databases, 
the latter also providing additional information on postoperative 
complications and neurological sequelae.
Complication phenotypes served for association analyses in Study 
III. Ranking the complications was based on univariable analyses 
with	 an	 mRS-score	 difference	 ≥3	 at	 between	 preoperative	 and	
hospital	discharge	scores.	This	cutoff	value	represents	an	increase	
which results in a dependent functional status for a preoperatively 
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asymptomatic (mRS score 0) patient. Complications reaching signif-
icance in univariable analyses were then entered into multivariable 
logistic regression analysis. After multivariable analysis, the most 
significant	complications	were	first	ranked	in	order.		Second	came	
all major, followed by all minor complications which failed to reach 
statistical	significance;	these	were	ranked	in	order	by	frequency.	For	
each patient, his/her highest-ranking complication phenotype was 
the one assigned.
4.3.6 30-day outcome variables and scores 
Those patients surviving the 30-day follow up were contacted by tele-
phone, and a study anesthesiologist conducted a structured interview. 
The questions addressed possible remaining neurological symptoms 
attributable to the surgery, severity of the possible symptoms (none, 
mild, or severe) and postoperative living arrangements (dependence 
on	the	aid	of	relatives	or	nursing	staff).	The	mRS	was	re-assessed	by	
means of a validated telephone mRS questionnaire.31 In addition, 
the patients reported their perceived overall health status (excellent, 
good, average, poor, very poor), and their overall satisfaction (ex-
cellent, good, satisfactory, poor, very poor) with the treatment they 
received during hospitalization. For statistical analyses, severity of 
symptoms	was	categorized	as	insignificant	(none	or	mild)	or	signifi-
cant (severe), overall health as good (average, good, or excellent) or 
poor (poor or very poor), and patient satisfaction as high (good or 
excellent) and low (satisfactory, poor, or very poor). 
After the 30-day follow-up, a study anesthesiologist manually 
retrieved data on reoperations involving the head for the time period 
between hospital discharge and the end of the 30-day follow-up. The 
Population Register Center of Finland provided 30-day mortality data 
for the study cohort.
4.3.7 Study outcome measures
We recorded both in-hospital and 30-day mortality rates. Mortality, 
however, is a crude outcome measure in the context of elective cranial 
neurosurgery,	with	statistically	significant	associations	expected	only	
in very large cohorts. Thus, composites of short-term adverse events 
(complications/morbidities) were our choice as primary outcome 
measures, inclusive or noninclusive of in-hospital mortality depend-
ing on the situation. Additionally, resource use [ICU and in-hospital 
length of stay (LOS)] served as an outcome measure (Study II). 
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4.3.7.1 New CNS deficits (II)
In Study II, one outcome comprised new permanent or transient 
central	nervous	system	(CNS)	deficits	defined	as	new	or	worsened	
hemiparesis, or stroke (clinical and/or radiological). 
4.3.7.2 Systemic and infectious complications (II)
Systemic and infectious complications in Study II comprised the 
following conditions recorded during hospitalization or at hospital 
discharge: DVT, PE, acute myocardial infarction (AMI), pneumonia, 
and WI or asymptomatic meningitis. 
4.3.7.3 Major morbidity (III, IV, V)
For Studies III, IV, and V, short-term postoperative complication 
categories included major and minor complications.  The composite 
outcome	measure	“major	morbidity”	used	in	these	three	studies	com-
prised new or worsened hemiparesis, silent stroke, DVT, PE, AMI, 
pneumonia,	in-hospital	mortality	(unless	otherwise	specified),	and	
unplanned re-craniotomy (CRT) or endovascular intervention (EI) 
within the 30-day follow-up (Table 11 ).  
4.3.7.4 Overall morbidity (III, IV, V) 
Overall	morbidity	was	defined	in	studies	III	and	IV	as	major	and/
or minor morbidity. The short-term postoperative adverse events 
categorized as minor morbidity were: asymptomatic meningitis/
WI, minor infections such as urinary tract infection or conjunctivitis, 
SVD, new or worsened facial nerve palsy, dysphasia or dysarthria, 
dysphagia, and unplanned minor cranial reoperations such as ven-
triculostomy or wound revision in the OR (Table 11).
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Table 11. Study outcome measures.
Time of recording Any time during 
hospitalization
At hospital dis-
charge, 
max 30 days
30 postoperative days
Data collection methods • Patient-reported questionnaire
• Anesthesiologist-completed study 
form
• Systematic manual retrieval from 
hospital patient records by study 
anesthesiologist
• Anesthesiologist-
completed study form
• Systematic manual 
retrieval from hospi-
tal patient records/
OR-management 
database by study 
anesthesiologist
Overall 
morbid-
ity
Major 
morbidity
• In-hospital  
mortality*
• 30-day mortality*
• Unplanned re-CRT 
or EI
New CNS 
deficits
• Silent stroke • New or worsened 
hemiparesis
SI compli-
cations
• AMI
• Pneumonia
• PE
• DVT
Minor 
morbidity
• Minor  
infections 
• SVD
• New or  
worsened 
facial nerve 
palsy
• Dysphasia or 
dysarthria
• Dysphagia
• WI or  
asymptomatic 
meningitis
• Unplanned minor  
cranial reoperations
   (in OR)
 – ventriculostomy
 – wound revision
AMI, acute myocardial infarction; CNS, central nervous system; CRT, craniotomy; DVT, deep venous 
thromboembolism; EI, endovascular intervention; OR, operating room; PE, pulmonary embolism; SI, systemic and 
infectious; SVD, subjective visual disturbances; WI, wound infection.
*Unless otherwise specified
Adapted from “Patient satisfaction and short-term outcome in elective cranial neurosurgery” by Reponen et al., 
Neurosurgery: November 2015 – Volume 77 – Issue 5 – p 769-776 (Study IV). Printed with permission from Wolters 
Kluwer Health Lippincott Williams & Wilkins©
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4.3.8 Statistical methods
The IBM® SPSS® 21.0 statistical software for Microsoft (MS®) Win-
dows and Macintosh Operating System (Mac OS®) X served for statis-
tical analyses.  Nominal data is presented as numbers (percentages). 
Odds	ratios	(ORs)	and	95%	confidence	intervals	(CIs)	are	reported	
where appropriate. The statistical tests and statistics included the 
Pearson Chi Square test or Fisher’s Exact test for categorical variables 
(II, III, IV, V), the Mann-Whitney U-test or Kruskall-Wallis test for 
continuous or ordinal variables (II, III, IV, V), and multivariable lo-
gistic regression analyses (II, III, V). Furthermore, sensitivity (III, V) 
specificity	(III,	V),	positive	predictive	value	(PPV)	(III),	and	negative	
predictive value (NPV) (III) were calculated for outcome predictors 
and	measures.	In	all	analyses,	significance	was	at	p<0.05.	
4.3.8.1 Pearson Chi Square test
The Pearson Chi Square test is applicable for unpaired categorical 
data from large samples. It is calculated by cross tabulation of the 
categorical variables, which should be mutually exclusive. Two con-
ditions	must	be	met:	first,	a	maximum	of	20%	of	the	expected	values	
can	be	less	than	five,	and	second,	none	of	the	expected	values	can	
be	less	than	one.	The	test	evaluates	the	statistical	significance	of	the	
differences	of	the	observed	frequency	ratios	in	the	contingency	table.	
In other words, it tests how likely it is that any distribution observed 
is due to chance. The null hypothesis is no statistical dependence be-
tween variables. The Chi Square test is meant to test the probability of 
independence of a distribution of data, but will not clarify the quality 
of the relationship between variables. Furthermore, for contingency 
tables larger than 2 x 2, post hoc analyses are essential to determining 
those	groups	between	which	the	difference	is	statistically	significant.	
4.3.8.2 Fisher’s Exact test
Fisher’s exact test is usually applied to unpaired categorical data 
in small samples if conditions for the Pearson Chi-Square test are 
unmet. It is valid, however, for all sample sizes. Fisher’s Exact test 
examines	the	significance	of	any	association	between	the	two	groups.	
The	p-value	is	computed	as	if	the	margins	of	the	table	are	fixed.	The	
null hypothesis is independence. 
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4.3.8.3 Odds ratio 
Odds	ratio	(OR)	is	a	measure	of	the	effect	size	describing	the	strength	
of association or nonindependence between two binary variables. OR 
is calculated by dividing the ratio of positive observations to nega-
tive observations in group A by the ratio of positive observations to 
negative	observations	in	group	B.	If	OR	equals	one,	no	difference	
exists between the two groups. If OR is greater than one, the ratio of 
positive-to-negative observations in group A is greater than in group 
B. If OR is less than one, the ratio of positive-to-negative observations 
in group A is smaller than in group B. A 95% CI is usually reported 
along	with	OR	to	help	determine	the	statistical	significance.	If	the	
number	“1”	is	included	in	the	CI,	the	difference	is	not	statistically	
significant.	
4.3.8.4 Mann-Whitney U-test
The Mann-Whitney U-test, also known as the Wilcoxon 2-sample 
test or Wilcoxon rank-sum test, examines two independent samples 
(groups). It is the nonparametric equivalent for Student’s t-test. This 
test is applicable when a numeric variable is not normally distributed 
or	the	variable	is	ordinal.	This	test	compares	differences	in	location	
of the distribution of two independent samples, the null hypothesis 
being	no	difference.	Rather	than	using	the	actual	observed	values	
in the calculations, the Mann-Whitney U-test is based on assigned 
numeric ranks for all observations and involves calculating rank sums 
in order to gain the U-statistic and p-value.
4.3.8.5 Kruskall-Wallis test
The Kruskall-Wallis test is the nonparametric equivalent of one-way 
analysis of variance (ANOVA), and tests whether samples originate 
from the same distribution. This test does not assume normal distri-
bution. The Kruskall-Wallis test, an extension of the Mann-Whitney 
U-test, serves to compare two or more independent samples. If the 
null	hypothesis	is	rejected,	at	least	one	group	statistically	differs	from	
at least one other group. The Kruskall-Wallis test does not, howev-
er, identify where this occurs or for how many pairs of groups, but 
post-hoc tests (pairwise Mann-Whitney U-tests, with their p-values 
corrected with, for example, Bonferroni correction) are necessary. 
Like the Mann-Whitney U-test, the Kruskall-Wallis test is based on 
assigned ranks and rank sums. 
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4.3.8.6 Linear and logistic regression analyses
Linear regression analysis examines the linear association between 
independent and dependent variables, both of which are numeric. 
The model can include one or multiple independent variables. The 
method assumes independence of the observations, a linear associ-
ation between the independent and dependent variables, a normal 
distribution of the dependent variable with every combination of 
independent variables, and homoscedasticity (homogeneity of vari-
ance). 
Logistic regression analysis is applicable to situations in which 
the dependent variable is categorical. The model can include one or 
multiple categorical or numerical covariates or both. If the dependent 
variable is binary, the method is called binary logistic regression. 
A rule of thumb dictates that one independent variable or covari-
ate for each ten observations can be added to the model. Selecting 
the independent variables and covariates requires solid theoretical 
knowledge	of	the	field.	Selection	is	usually	based	on	statistical	sig-
nificance.	The	independent	variables	or	covariates	selected	should	
be tested by collinearity diagnostics because strong intercorrelations 
would lead to multicollinearity. 
4.3.8.7 Sensitivity, specificity, positive predictive value (PPV),  
 and negative predictive value (NPV)
Sensitivity	and	specificity	measure	the	performance	of	a	binary	test	
such as a diagnostic test with either a positive or a negative result. 
Sensitivity measures the proportion of true positives correctly iden-
tified	as	such.	In	other	words,	sensitivity	is	the	percentage	of	sick	
people	who	are	correctly	identified	by	a	positive	result	in	a	diagnostic	
test	(true-positive	rate).	Specificity	describes	the	proportion	of	true	
negatives	correctly	identified	as	such.	Thus,	specificity	is	the	percent-
age	of	healthy	individuals	who	are	correctly	identified	by	a	negative	
result in a diagnostic test (true-negative rate) (Figure 2).
PPV is the proportion of positive results in a diagnostic test that 
are true positives. In other words, PPV is the probability that patients 
with a positive test result in fact have the disease. NPV is the propor-
tion of negative results in a diagnostic test that are true negatives. 
NPV is the probability that patients with a negative test result are in 
fact	healthy.	Like	its	sensitivity	and	specificity,	PPV	and	NPV	describe	
the performance of a diagnostic test. PPV and NPV depend on the 
prevalence of the condition (Figure 2). 
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Figure 2. Calculating sensitivity, specificity, PPV, and NPV.
sick healthy
test positive a b a+b
test negative c d c+d
a+c b+d N=a+b+c+d
Sensitivity= a/(a+c) PPV= a/(a+b)
Specificity= d/(b+d) NPV= d/(c+d)
4.3.8.8 Receiver operating characteristics (ROC) curve and area  
 under the curve (AUC)
The ROC curve is a graph of the positive likelihood ratios in which the 
Y axis represents the proportion of true-positive results (sensitivity) 
and the X axis represents the proportion of false-positive results (1 
minus	specificity).	A	ROC	curve	serves	for	presenting	the	charac-
teristics of a diagnostic test. The area under the ROC curve (AUC) 
represents the accuracy of the diagnostic test in detecting the disease 
and ranges from 0.5 (worthless test) to 1.0 (perfect test). An AUC of 
0.5 indicates that the test results are no better than chance, and the 
test with the largest AUC is considered the most accurate. 
4.3.9 Ethical aspects
The study protocol was reviewed and approved by the ethics com-
mittee and the institutional board of the Hospital District of Helsinki 
and Uusimaa. The study was observational in design, and all pre-
operative, perioperative, and postoperative evaluations and treat-
ments adhered to the standard clinical practice of the Department 
of Neurosurgery. Each patient signed an informed consent prior to 
enrollment and all were informed of their right to 
withdraw from the study at any point. Completing 
the questionnaires was not considered a burden for 
the patients, because the number of questions was 
limited, and completing the questionnaires took 
only a few minutes. Severely ill patients or patients 
with advanced cognitive dysfunction, for whom 
participating would have caused too much strain or 
who were unable to understand the study protocol, 
were excluded. Nonparticipation or withdrawal had 
no	effect	on	the	patients’	clinical	treatment. 
MR image showing a low-grade glioma in the temporal lobe 
and adjacent insular cortex.  
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5. RESULTS
5.1 Results of the systematic review (I)
Study I included 25 studies, each reporting the use of at least one 
preoperative risk-assessment score. 
5.1.1 ASA Physical Status Classification score
Evidence	for	use	of	the	ASA	classification	in	elective	cranial	neurosur-
gery is scarce. In Study I, we reported a total of 10 studies that assess 
the	role	of	the	ASA	classification	in	preoperative	risk	prediction.75, 
78-80, 82-85, 114, 115 Only two of these studies clearly stated whether the 
surgeries were elective, emergency or a collection of both. Only one 
study was prospective. Eight studies, including the only prospective 
study,	reported	a	positive	association	between	the	ASA	classification	
and outcome. The main shortcomings of the existing studies were 
poorly	defined	outcome,	relatively	small	size	(<300	patients)	in	8,	
retrospective design in 9, and failure to report short-term (<30-day) 
morbidity and mortality in 5 studies.
In two retrospective studies, the primary outcome was sur-
gery-related. The conclusions of the two studies were contradictory: 
in one, on patients with unruptured intracranial aneurysms (157 
craniotomies),	only	calcification	of	the	aneurysm	correlated	with	
poor outcome (Glasgow Outcome Scale <4) at 6 months,85 whereas 
in elderly meningioma patients, a preoperative ASA score of 3 or 4 
predicted a Karnofsky Performance Score (KPS) of 70 or less at the 
4-month follow-up.78
In two studies with nonsurgical outcomes, a preoperative ASA 
score	≥2	predicted	surgical	site	infections,115 and higher preoperative 
ASA scores were associated with an increased incidence of postop-
erative meningitis.114 
An association between preoperative ASA score 3 or more and 
postoperative morbidity emerged in two retrospective studies on 
patients with meningiomas and malignant tumors.82, 83 Mortality was 
the primary outcome in four retrospective studies on elderly patients 
with intracranial meningiomas;75, 79, 80, 84 three of these studies report-
ed	a	significant	association	between	high	ASA	scores	and	mortality,75, 
79, 84	whereas	one	study	confirmed	no	such	association.80 
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In	conclusion,	 the	role	of	 the	ASA	classification	in	predicting	
outcome after elective cranial neurosurgery is somewhat ambiguous 
(Table 12). Evidence suggests that it may be useful for predicting 
infectious complications and, possibly, postoperative functional 
status.78, 114, 115 
5.1.2 KPS score
Our systematic review (Study I) provided 16 studies on the applicability 
of KPS to preoperative outcome prediction in cranial neurosurgery.75, 
78-81, 83, 84, 86-94 Of these studies, three were prospective.81, 91, 92 Only one 
study reported whether the surgeries were elective, emergency, or 
both.81 Altogether 14 studies concluded that a positive association 
existed between KPS and postoperative outcome.75, 78-81, 83, 84, 86, 87, 89, 91-94 
Six studies assessed KPS in predicting a surgery-related out-
come.78, 81, 88, 91, 93, 94 The results of two prospective studies81, 91 and three 
retrospective studies78, 93, 94 supported the use of KPS. KPS predicted 
neurological outcome in 21-day follow-up in a prospective cohort of 
over 400 patients with malignant gliomas.91	No	significant	change	in	
preoperative versus postoperative KPS at 6 months was detectable in 
a prospective study of patients with high-grade gliomas, indicating 
a positive prognostic association.81 A retrospective study of patients 
with insular gliomas concluded that a high preoperative KPS was 
associated with a favorable outcome (KPS >80) in a 3-month follow 
up. Preoperative KPS 70 or less was predictive of a poor postoper-
ative outcome (KPS 70 or less) in elderly patients with intracranial 
meningioma.78 In patients with meningiomas, KPS was associated 
with	early	(1	week)	but	not	late	(3	months)	neurological	deficits.94 One 
study	reported	no	significant	association	between	preoperative	KPS	
and postoperative neurological status or operative complications in 
intra-axial brain tumor patients.88
Three retrospective studies reported associations between KPS 
and nonsurgical outcomes.86-88 Low preoperative KPS associated with 
postoperative systemic complications such as pneumonia, acute heart 
failure, acute renal failure, and sepsis in elderly patients with intra-
cranial tumors during a 4-week follow-up.86 A retrospective study 
with a large cohort (over 4000 patients) with intracranial tumors 
reported	a	significant	association	of	preoperative	KPS	70	or	less	with	
the development of DVT or PE within 30 days after craniotomy.87 No 
significant	association	between	preoperative	KPS	and	systemic	com-
plications	was	identifiable	in	patients	with	intra-axial	brain	tumors.88
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Five studies reported overall morbidity as their outcome.83, 88-90, 92 
In patients with supratentorial tumors, KPS 50 or less correlated with 
a complicated outcome (neurological, medical, or operative complica-
tions).89 KPS associated with postoperative complications, including 
hematomas,	local	infections,	fistulas,	thromboembolic	complications,	
sepsis, and cardiac failure within a 30-day follow-up in patients 
with malignant intracranial tumors.83 No association between the 
preoperative KPS and postoperative morbidity or 30-day mortality 
was	identifiable	in	patients	with	gliomas/metastases	and	intra-axial	
brain tumors.88, 90 KPS was unassociated with prolonged hospital 
stay, life-threatening situation, reintervention, or readmission.90 In 
patients with gliomas or metastases, preoperative KPS correlated 
with 30-day mortality but not with morbidity.92 A preoperatively high 
KPS score associated with postoperative mortality in elderly patients 
with meningiomas.75, 78-80, 84 
In conclusion, KPS has substantial evidence as a risk-assessment 
tool for patients with intracranial tumors regardless of the nature 
of the tumor both for short-term80, 83, 86, 89, 91-94 and long-term75, 78, 
80, 81, 84, 93, 94 postoperative outcomes (Table 12). Evidence supports 
the applicability of preoperative KPS in predicting surgery-related 
outcomes	with	a	positive	correlation	reported	in	four	of	five	studies.	
Furthermore,	five	of	seven	studies	reported	a	positive	correlation	
between low preoperative KPS and postoperative mortality. 
 5.1.3 mRS score
Our systematic review (Study I) found two studies using mRS for 
preoperative prediction of postoperative outcome in cranial neuro-
surgery.96, 97	The	results	of	the	two	studies	were	conflicting:	Low	mRS	
score was an independent predictor of surgical outcome at 1-year 
follow-up in patients with brainstem cavernous malformations,97 
but in patients with unruptured posterior circulation aneurysms, 
preoperative	mRS	score	was	a	significant	predictor	of	neither	sur-
gical morbidity nor mortality.96 As shown in Table 12, evidence as 
to the applicability of mRS as a preoperative risk score in elective 
craniotomy patients is very limited. 
5.1.4 Charlson comorbidity score
In	Study	 I,	we	 identified	 three	 large	 register-based	retrospective	
studies on the applicability of the Charlson Comorbidity Score in 
preoperative risk assessment of craniotomy patients.99-101 Two studies 
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included both emergency and elective patients, but for the third study 
this information was unavailable. The Charlson comorbidity score 
was associated with in-hospital mortality in patients with unruptured 
intracranial aneurysms.101 In elderly patients with metastatic brain 
tumors, each 1-point increase in Charlson comorbidity score raised 
the odds of inpatient death by 12% and odds of stroke or pulmonary 
complications and also length of hospitalization.99 Furthermore, 
the Charlson comorbidity score was associated with higher odds of 
inpatient death and major postoperative complications in elderly 
patients with intracranial meningioma.100
Even though all three studies suggested a positive correlation 
between the Charlson comorbidity score and postoperative outcome 
(Table 12), their results should be interpreted cautiously since two 
of the three came from the same authors at Johns Hopkins, in Balti-
more, Maryland, so the external validity of the results may be limited. 
5.1.5 SKALE score
Our systematic review (Study I) found only two retrospective studies 
utilizing the SKALE score.75, 84 Each, with limited patient numbers 
and	outcome	defined	as	mortality	at	12	months,	reached	the	opposite	
conclusion. The SKALE score added no value when compared to the 
ASA score in predicting the postoperative outcome in meningioma 
patients.84 In elderly meningioma patients, however, a SKALE score 
of	8	or	higher	was	associated	with	a	significantly	reduced	postoper-
ative mortality.75 Existing studies, thus, suggest that SKALE may be 
useful in predicting long-term postoperative mortality (Table 12), but 
studies linking preoperative SKALE score and short-term outcome 
are lacking.
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5.2 Short-term postoperative complications  
 (II, III, IV) and complication phenotypes (III)
In-hospital complication data were available for all 418 study pa-
tients.	A	total	of	194	(46.4%)	patients	suffered	from	overall	morbidity,	
whereas the rate of major morbidity (including in-hospital mortality) 
was 18.2% (76 patients) (IV). The most common major complication 
was new or worsened hemiparesis (41 patients, 9.8%). The rate of 
unplanned re-craniotomy or endovascular intervention was 4.1% (17 
patients). Pneumonia was diagnosed in 14 (3.3%) patients. Silent 
stroke was detectable in the radiological imaging studies of 6 (1.4%) 
patients. Other major complications were rare; AMI in 4 patients 
(1.0%), PE in 3 (0.7%), and DVT in 2 (0.5%). 
In the 121 patients with malignant tumors as an indication for the 
craniotomy, the rates of new or worsened hemiparesis (17 patients, 
14.0%), re-craniotomy or endovascular intervention (7, 5.8%), DVT 
(2, 1.7%), and PE (2 patients, 1.7%) were higher than in the whole 
study cohort. The 135 patients undergoing craniotomy for benign 
tumors had higher rates of silent strokes (3 patients, 2.2%), AMI (3, 
2.2%), and re-craniotomy or endovascular intervention (8, 5.9%) 
than did the whole cohort. The 138 cerebrovascular surgery patients 
(n=138) less frequently had new hemiparesis (10 patients, 7.2%), 
Table 12. Summary of applicability of proposed scores in elective 
cranial neurosurgery. Number of studies in parentheses.
Surgery-related Nonsurgical Morbidity Mortality
+ - + - + - + -
Malignant 
tumor
KPS (3) ASA (1)
KPS (1)
Charlson (1)
KPS (2) KPS (1)
Charlson (1)
KPS (1)
Benign 
tumor
ASA (1)
KPS (2)
ASA (1)
Charlson (1)
ASA (3)
KPS (4)
Charlson (1)
SKALE (2)
ASA (1)
Tumors (not 
specified)
KPS (1) KPS (2) KPS (1) KPS (1) KPS (1) KPS (1)
Vascular mRS (1) ASA (1)
mRS (1)
Charlson (1) mRS (1)
Mixed ASA (2)
+, study results support use; -, study results do not support use; ASA, American Society of Anesthesiologists Physical Status Score; 
Charlson, Charlson comorbidity score; KPS, Karnofsky Performance Score; mRS, modified Rankin Scale; SKALE, Sex, Karnofsky, 
ASA, Location, Edema -score.
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silent stroke (1 patient, 0.7%), and recraniotomy or endovascular 
intervention (1, 0.7%) but more frequently pneumonia (6, 4.3%) than 
did the whole study cohort.
Altogether	159	patients	(38.0%)	suffered	from	minor	complica-
tions, 118 of them without any major complication. The minor compli-
cation most frequently reported was SVD in 76 patients (18.2%). The 
rate of dysphasia or dysarthria was 11.7% (49) and minor infections 
were recorded in 39 (9.3%). Dysphagia was recorded in 26 patients 
(6.2%). Rare conditions were new or worsened facial nerve palsy (14 
patients, 3.3%), WI/meningitis (9 patients, 2.2%), and unplanned 
minor cranial reoperations in the OR (3 patients, 0.7%).
The	 complication	 profile	 in	 patients	 aged	 ≥65	 years	 differed	
from that of younger patients. The elderly were more susceptible 
to infectious complications, major new CNS defects, PE, AMI, and 
suffered	more	in-hospital	mortality	(Figure	3).	The	rate	of	major	
complications in the subgroup of elderly patients was 25.0% and of 
overall complications, 51.6%.
 
Figure 3. Complication rates in age subgroups.
All patients, n=418
Age ≥65 years, n=124
Age ≤65 years, n=294
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AMI, acute myocardial infarction; CRT, craniotomy; DVT, deep venous thromboembolism; EI, endovascular 
intervention; PE, pulmonary embolism; WI, wound infection.
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After multivariable analyses for complication phenotypes, only 
three	individual	complications	retained	their	significance	(III).	New	
or worsened hemiparesis (p<0.001), silent stroke (p<0.001), and 
pneumonia	(0=0.005)	were	associated	with	an	mRS-score	difference	
>2 from preoperative to hospital discharge score. For complication 
phenotypes, see Table 13.
Table 13. Complication phenotypes in 194 patients with reported postoperative complications.
Complication phenotypes ranked in order Patients, n=194
Hemiparesis 41 
Silent stroke 6 
Pneumonia 8 
re-CRT or EI 14 
AMI 2 
PE 2 
DVT 2 
SVD 64
Speech impairment 25
Minor infection 19 
Dysphagia 7 
Facial nerve palsy 2 
Meningitis/WI 2 
Minor cranial reoperation 0 
AMI, acute myocardial infarction; CRT, craniotomy; DVT, deep venous thromboembolism; EI, endovascular 
intervention; PE, pulmonary embolism; SVD, subjective visual disturbances; WI, wound infection
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5.3 Outcome measures
5.3.1 New CNS deficits (II)
New	CNS	deficits	were	identified	in	47	(11.2%)	patients	(II).	Of	the	
surgical indications, patients with malignant tumors had the highest 
rate	of	new	CNS	deficits,	15.7%	(Table	14).		
5.3.2 Systemic and infectious complications (II)
Systemic and infectious complications occurred in 28 (6.7%) patients 
(II).	One-eighth	(12.1%)	of	elderly	patients	(≥65	years)	and	one-tenth	
(10.4%) of patients with preoperative C-reactive protein (CRP) >3 mg/l 
suffered	from	systemic	and	infectious	complications	(II).	For	rates	of	
systemic and infectious complications in various patient subgroups, 
see Table 14.
5.3.3 Major morbidity (III-V)
The rate of major morbidity in the whole study cohort was 18.2% 
(76 patients) (III, IV). Elderly patients had a higher major morbidity 
rate than did the whole cohort, also by patient subgroup (Table 14). 
Especially in patients undergoing intracranial vascular surgery, the 
rate	of	major	morbidity	almost	doubled	in	patients	aged	≥65.	
5.3.4 Overall and minor morbidity (III-V)
Altogether	194	patients	suffered	from	at	least	one	of	the	recorded	
complications, making the overall morbidity rate 46.4%. Minor com-
plications occurred in 159 (38.0%) patients, of whom, 118 (74.2%) 
had	no	major	morbidity.	Patients	aged	≥65	with	intracranial	vascular	
surgery had the highest rates of overall (69.0%) and minor (65.5%) 
morbidity. Elderly patients with benign tumors, when compared with 
all benign tumor patients, had a lower rate of overall morbidity (47.7% 
versus 51.1%) (Table 14) and minor morbidity (29.5% versus 43.0%). 
5.3.5 In-hospital and 30-day mortality (II-V)
Altogether 4 study patients died during the in-hospital period and 
an additional 6 within the 30-day follow-up. Thus, the in-hospital 
mortality rate was 1.0%, and 30-day mortality rate 2.4% (Table 14). 
All deceased patients were 64-year-olds or older. The characteristics 
of	the	deceased	patients	and	their	specific	postoperative	complications	
are in Table 15.
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Table 15. Characteristics of the 10 deceased patients.
Patient 
number
Age 
(years)
Sex Indication Comorbidities Postoperative 
complications
1 75 Female Benign tumor Atrial fibrillation
Cerebrovascular 
incident
Diabetes mellitus
AMI
2 67 Female Benign tumor Problems with memory Stroke
Tracheostomy
3 85 Female Benign tumor 3rd degree AV-block 
with pacemaker
Toxic struma
Rhabdomyolysis 1 
month before surgery
Sudden death*
4 66 Male Malignant tumor 
(metastasis)
Endocarditis 1 month 
before surgery
Stroke 2 months before 
surgery
Cancer with brain 
metastasis, primary 
focus unknown
Hypertension
Hypercholesterolemia
Stroke
AMI
Pneumonia
5 64 Male Malignant tumor WPW syndrome
Previous DVT and PE
Epilepsy
Hypothyroidism
DVT
6 84 Male Malignant tumor Lymphoma
Crohn’s disease
Pneumonia
7 77 Male Malignant tumor Previous AMI
Exposure to asbestos
Hemiparesis
8 85 Male Malignant tumor Atrial fibrillation
Psoriatic arthritis
Pneumonia
9 65 Male Malignant tumor Previous AMI
Asthma, COPD
Previous pneumonia
Previous PE
APC resistance 
(coagulation 
abnormality)
Urinary tract 
infection
10 85 Female Benign tumor CAD
Hypertension
Glaucoma 
Dysphagia
Patients 1-4 died before hospital discharge. Patients 5-10 died after being discharged from Töölö hospital, within 30 
days of the primary operation.
AMI, acute myocardial infarction; AV, atrioventricular; CAD, coronary artery disease; COPD, chronic obstructive 
pulmonary disease; DVT, deep venous thromboembolism; PE, pulmonary embolism; WPW, Wolff-Parkinson-White.
*Asystole and resuscitation on 3rd postoperative day, massive PE in autopsy. 
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5.3.6 Length of stay (LOS)
5.3.6.1 ICU LOS (II)
The mean ICU LOS was 1.3 days [standard deviation (SD) 1.4] and me-
dian 1.0 (range 0-13) (II). The ICU stays in patient subgroups by surgical 
outcome	measures	are	presented	in	Table	16.	In	patients	aged	≥65	years,	
the mean ICU LOS was 1.4 days (SD 1.2) and median 1.0 (range 1-11). 
5.3.6.2 Hospital LOS (II)
The mean hospital LOS was 5.6 days (SD 3.5 days) and median 5.0 
days (range 1-34 days) (II). The hospital stays in patient subgroups 
by surgical outcome measures are in Table 16. In elderly patients, the 
mean hospital LOS was 6.1 days (SD 3.3) and median 5.0 (range 1-16).
Table 16. ICU and hospital LOS in patient subgroups by surgical outcome measures.
Patient subgroups
No complications
Major 
morbidity Overall morbidity
n=224 n=76 n=194 
ICU LOS in days
mean (SD)
median (range)
1.0 (0.2)
1.0 (0-2)
2.3 (2.9)
1.0 (0-13)
1.6 (2.0)
1.0 (0-13)
Hospital LOS in days
mean (SD)
median (range)
4.6 (2.3)
4.0 (1-23)
8.1 (5.7)
6.0 (2-34)
6.7 (4.2)
6.0 (1-34)
ICU, intensive care unit; LOS, length of stay, SD, standard deviation
5.4 Preoperative risk-assessment methods
5.4.1 Preoperative risk-assessment scores 
5.4.1.1 ASA Physical Status score (II)
Preoperative ASA scores were available for 417 (99.8%) patients. For 
their	distribution,	see	Figure	3.	Of	patients	aged	≥65	years,	17	(13.7%)	
had preoperative ASA score 4. In Study II, preoperative ASA score 
groups	did	not	differ	with	regard	to	systemic	and	infectious	compli-
cations	(p=0.213),	new	CNS	deficits	(p=0.408),	ICU	LOS	(p=0.095),	
or hospital LOS (p=0.389). The associations of high preoperative ASA 
score with study outcome measures are in Table 17. Of individual com-
plications, only AMI (p=0.031, OR and CI not calculable), dysphagia 
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(p=0.010, OR 4.2, CI 1.6-11.4), and minor cranial reoperations in the 
OR (p=0.016, OR 25.6, CI 2.3-290.5) were statistically associated 
with preoperative ASA score >3. 
5.4.1.2 Helsinki ASA score (II)
Preoperative Helsinki ASA scores were available for 417 patients. 
For their distribution, see Figure 4. The preoperative ASA score 
was	4	for	33	(26.6%)	patients	aged	≥65.	In	Study	II,	Helsinki	ASA	2	
group	differed	from	the	Helsinki	ASA	3	(p=0.027)	or	Helsinki	ASA	4	
(p=0.002) groups in predicting systemic and infectious complications. 
The	Helsinki	ASA	groups	did	not	differ	with	regard	to	new	CNS	deficits	
(p=0.663) (II). The Helsinki ASA 4 group had longer ICU stays than 
did the Helsinki ASA 2 (p=0.015) or Helsinki ASA 3 (p=0.013) groups 
(II). Additionally, the Helsinki ASA 2 group had shorter hospital stays 
than did the Helsinki ASA 3 (p=0.022) or Helsinki ASA4 (p=0.001) 
groups	(II).	These	associations	remained	significant	after	multivariable	
logistic regression analyses (categorical outcome variables) and multi-
variable linear regression analyses (continuous outcome variables) (II).
Table 17 presents the associations between high preoperative 
Helsinki ASA score and study outcome measures. The only individ-
ual complications associated with preoperative Helsinki ASA score 
>3 were pneumonia (p<0.001, OR 10.5, CI 3.4-32.4) and dysphagia 
(p=0.023, OR 3.0, CI 1.3-7.0).
Figure 4. Distribution of preoperative ASA scores and Helsinki ASA scores. Only elective craniotomy 
patients were enrolled and thus no patients with scores >4 were included in the study cohort.
ASA score
Patients (%)
N=417
Helsinki ASA 
score
Patients (%)
N=417
1 67 (16.1) 1 4 (1.0)
2 152 (36.5) 2 94 (22.5)
3 166 (39.8) 3 251 (60.2)
4 32 (7.7) 4 68 (16.3)
Preoperative ASA score Preoperative Helsinki ASA score
ASA score 1
ASA score 2
ASA score 3
ASA score 4
Helsinki ASA score 1
Helsinki ASA score 2
Helsinki ASA score 3
Helsinki ASA score 4
ASA, American Society of Anesthesiologists Physical Status Classification. 
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New CNS deficits
p OR 95%CI sens (%) spec (%) PPV (%) NPV (%) AUC
ASA 0.155 1.9 0.8-5.0 12.8 93.0 18.8 89.4 0.503
Helsinki ASA 0.328 1.5 0.7-3.1 21.3 84.3 14.7 89.4 0.543
mRS 0.043 2.3 1.0-5.2 19.1 90.8 20.9 89.8 0.572
Charlson 0.323 1.4 0.7-2.7 31.9 74.8 13.9 89.6 0.579
Systemic and infectious complications
p OR 95%CI sens (%) spec (%) PPV (%) NPV (%) AUC
ASA 0.256 2.1 0.7-6.6 14.3 92.8 12.5 93.8 0.609
Helsinki ASA 0.030 2.6 1.1-6.1 32.1 84.8 13.2 94.6 0.655
mRS 0.017 3.3 1.3-8.2 25.0 90.7 16.3 94.4 0.651
Charlson 0.003 3.1 1.4-6.8 50.0 75.8 13.0 95.5 0.642
Major morbidity
p OR 95%CI sens (%) spec (%) PPV (%) NPV (%) AUC
ASA 0.131 1.9 0.8-4.2 11.8 93.3 28.1 82.6 0.556
Helsinki ASA 0.114 1.6 0.9-3.0 22.4 85.0 25.0 83.1 0.567
mRS <0.001 3.5 1.8-6.8 22.4 92.4 39.5 84.2 0.610
Charlson 0.001 2.4 1.4-4.0 40.8 77.4 28.7 85.4 0.646
Overall morbidity
p OR 95%CI sens (%) spec (%) PPV (%) NPV (%) AUC
ASA 0.059 2.0 1.0-4.3 10.3 94.6 62.5 54.8 0.559
Helsinki ASA 0.002 2.3 1.3-3.9 22.3 88.8 63.2 57.0 0.577
mRS 0.004 2.6 1.3-5.1 14.9 93.7 67.4 55.9 0.559
Charlson 0.009 1.8 1.2-2.8 32.0 79.3 57.4 57.1 0.576
In-hospital mortality
p OR 95%CI sens (%) spec (%) PPV (%) NPV (%) AUC
ASA 0.031 12.8 1.7-93.9 50.0 92.7 6.3 99.5 0.749
Helsinki ASA 0.126 5.3 0.7-38.0 50.0 84.0 2.9 99.4 0.729
mRS 0.055 9.1 1.2-66.1 50.0 90.1 4.7 99.5 0.627
Charlson 0.055 8.8 0.9-85.2 75.0 74.5 2.8 99.7 0.799
30-day mortality
p OR 95%CI sens (%) spec (%) PPV (%) NPV (%) AUC
ASA <0.001 14.1 3.8-51.6 50.0 93.4 15.6 98.7 0.772
Helsinki ASA <0.001 13.2 3.3-52.6 70.0 85.0 10.3 99.1 0.811
mRS <0.001 15.0 4.0-55.6 60.0 90.9 14.0 98.9 0.769
Charlson <0.001 12.2 2.6-58.6 80.0 75.4 7.4 99.4 0.841
All ASA, Helsinki ASA, and mRS scores for 417 patients. Charlson comorbidity scores for 416 patients.
AMI, acute myocardial infarction; ASA, American Society of Anesthesiologists’  physical status classification; Charlson, Charlson 
comorbidity score; CI confidence interval; CNS, central nervous system; CRT, craniotomy; DVT, deep vein thrombosis; EI, 
endovascular intervention; mRS, modified Rankin Scale;  NPV, negative predictive value; OR, odds ratio; PE, pulmonary 
embolism; PPV, positive predictive value; sens, sensitivity; spec, specificity.
Table 17. Associations of preoperative ASA score (>3), Helsinki ASA score (>3), mRS 
score (>2), and Charlson comorbidity score (>2) with study outcome measures and AUC 
for each test. Significant associations in bold, Fisher’s Exact test results italicized. 
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5.4.1.3 mRS score
A preoperative mRS score was available for 417 patients (Figure 5). 
The mean preoperative mRS score was 1.26 (SD 1.1) and median 1 
(range	0-5).	A	majority	of	patients	aged	≥65	(98	patients,	79.0%)	
were	preoperatively	functionally	independent	(mRS	score	≤2).	Table	
17 shows associations between study outcome measures and high 
preoperative mRS score dichotomized at >2 indicating a dependent 
functional status. Of individual major complications, only pneumonia 
(p=0.001, OR 7.4, CI 2.4-22.5) was associated with high preoperative 
mRS score. Preoperative mRS score >2 was associated with increased 
hospital LOS (p=0.003) but not with increased ICU LOS (p=0.379). 
(Reponen et al., unpublished data)
Figure 5. Distribution of preoperative mRS scores.
 
Preoperative mRS score Patients (%)
N=417
0 107 (25.7)
1 158 (37.9)
2 109 (26.1)
3 27 (6.5)
4 13 (3.1)
5 3 (0.7)
200
150
100
50
0
Number of patients
Preoperative modified Rankin Scale scores
0  1  2  3  4  5
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5.4.1.4 Charlson comorbidity score
Of the 416 patients with available preoperative Charlson comorbidity 
scores,	almost	three-fourths	(308,	74.0%)	had	scores	≤2	(Figure	6).	
The respective mean and median Charlson comorbidity scores were 
2.1	(SD	1.8)	and	2.0	(range	0-9).	In	the	subgroup	of	patients	≥65	years	
old,	70	(56.6%)	had	Charlson	comorbidity	score	≤2.	Associations	
between study outcome measures and high preoperative Charlson 
comorbidity scores (dichotomized at >2) are in Table 17. Of individual 
major complications, only pneumonia (p=0.012, OR 4.0, CI 1.4-11.9) 
and PE (p=0.017, OR and CI not calculable) were associated with high 
preoperative Charlson comorbidity score. A preoperative Charlson 
comorbidity score >2 was associated with increased hospital LOS 
(p=0.039) but not with increased ICU LOS (p=0.350) (Reponen et 
al., unpublished data).
Figure 6. Distribution of preoperative Charlson comorbidity scores.
 
Preoperative Charlson 
comorbidity score
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0 91 (21.9)
1 33 (7.9)
2 184 (44.2)
3 44 (10.6)
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6 18 (4.3)
7 6 (1.4)
8 5 (1.2)
9 1 (0.2)
200
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5.4.2 Patient characteristics, patient-reported preoperative  
 variables and preoperative laboratory measurements (II)
Table 18 presents the preoperative clinical and laboratory measure-
ments. Preoperative patient-reported variables are in Table 19. In 
univariable analyses between patient characteristics and preoperative 
laboratory measurements and individual major complications, sig-
nificant	associations	were	detected	only	between	advanced	age	and	
pneumonia (p=0.004), lower Hb level and silent stroke (p=0.008), 
higher plasma potassium (K) level and AMI (p=0.014), higher plasma 
creatinine (Crea) level and PE (p=0.022), and advanced age and AMI 
(0.028). 
Differences	in	preoperatively	recorded	variables	(age,	sex,	weight,	
height, BMI, and additional variables in Table 18) in patients with 
and	without	new	CNS	deficits	failed	to	reach	statistical	significance	
(II).	Of	these	variables,	only	age	≥65  (p=0.004, OR 3.0, CI 1.4-6.5, 
sensitivity	53.6%,	specificity	72.1%,	PPV	12.1%,	NPV	95.6%),	BMI	in	
quartiles (p=0.024), and preoperatively elevated CRP dichotomized 
at	>3	mg/l		(p=0.046,	OR	2.2,	CI	1.0-5.1,	sensitivity	42.3%,	specificity	
75.4%, PPV 10.4%, NPV 95.1%) were associated with systemic and 
infectious complications (II). Male sex (p=0.044, OR 1.6, CI 1.0-2.8, 
sensitivity	48.0%,	specificity	64.4%,	PPV	22.8%,	NPV	85.0%)	and	
age	≥65	(p=0.019,	OR	1.8,	CI	1.1-3.1,	sensitivity	40.8%,	specificity	
72.8%, PPV 25.0%, NPV 84.7%) were the only variables associated 
with major morbidity. High blood glucose (p=0.032) was associated 
with	overall	morbidity.	Age	≥65	was	associated	with	both	in-hospital	
(p=0.007,	OR	and	CI	not	calculable,	sensitivity	100.0%,	specificity	
71.0%, PPV 3.2%, NPV 100.0%) and 30-day (p<0.001, OR 22.9, CI 
2.8-183.0,	sensitivity	90.0%,	specificity	71.8%,	PPV	7.3%,	NPV99.7%)	
mortality. Additionally, high heart rate (p=0.049), high blood glucose 
(p=0.006), and high preoperative CRP (0.014) were associated with 
in-hospital mortality. Variables associated with 30-day mortality in-
cluded high heart rate (p=0.041), low thrombocyte count (p=0.036), 
high blood glucose (p<0.001), high preoperative CRP (p=0.021), and 
high plasma sodium (p=0.002).
In univariable analyses for resource use, only high blood glucose 
(p=0.012)	and	high	or	 low	potassium	(p=0.025)	were	significant	
predictors	of	prolonged	ICU	LOS.	Significant	predictors	of	extended	
hospital LOS comprised high SBP (p=0.029), low Hb (p=0.019) (II).
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Table 18. Preoperative clinical and laboratory measurements
Patients Mean (SD) Median (range)
SBP (mmHg) 416 142.4 (20.5) 141 (95-224)
DBP (mmHg) 416 85.9 (11.3) 86 (46-137)
HR (beats/min) 415 70.1 (13.5) 68 (41-114)
Hb (g/l) 417 140.6 (12.2) 141 (105-180)
Platelets (E9/l) 417 245.3 (66.4) 238 (32-543)
Crea (µmol/l) 416 70.2 (16.3) 68 (5-160)
Gluc (mmol/l) 409 6.5 (2.6) 5.8 (3.9-24.8)
CRP (mg/l) 412 5.2 (7.4) 3 (3-77)
Na (mmol/l) 417 138.5 (4.0) 139 (123-158)
K (mmol/l) 417 4.0 (0.4) 4.0 (2.9-5.6)
PT (%) 410 112.2 (23.9) 108 (9-170)
SBP, systolic blood pressure; Crea; creatinine; DBP, diastolic blood pressure; Gluc, glucose; HR, heart rate; Hb, 
hemoglobin; CRP, C-reactive protein; Na, sodium; K, potassium; PT plasma prothrombin time.
MR image after surgery for occipital brain metastasis.
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Table 19. Preoperative patient-reported variables
   Variables
Vascular 
lesion
Patients (%)
Benign 
tumor
Patients (%)
Malignant 
tumor
Patients (%)
Other
Patients (%)
Age ≥65 
years
Patients (%)
All
Patients (%)
Smoking 
yes
ex-smoker
no
39 (30.7)
54 (42.5)
34 (26.8)
25 (21.0)
32 (26.9)
62 (52.1)
18 (17.3)
35 (33.7)
51 (49.0)
4 (18.2)
8 (36.4)
10 (45.5)
11 (10.8)
36 (35.3)
55 (53.9)
86 (23.1)
129 (34.7)
157 (42.2)
Alcohol use within 7 days 
none
moderate
excessive
67 (55.4)
52  (43.0)
2 (1.7)
62 (52.5)
55 (46.6)
1 (0.8)
78 (75.7)
25 (24.3)
0 (0.0)
13 (59.1)
9 (40.9)
0 (0.0)
71 (71.7)
28 (28.3)
0 (0.0)
220 (60.4)
141 (38.7)
3 (0.8)
Physical exercise habits 
never
< 1 time/week
1 time/week
2-3 times/week
≥ 4 times/week
18 (15.1)
22 (18.5)
19 (13.8)
33 (27.7)
27 (22.7)
11 (9.6)
24 (21.1)
21 (18.4)
35 (30.7)
23 (20.2)
22 (22.0) 
16 (16.0)
21 (21.0)
25 (25.0)
16 (16.0)
3 (13.6)
6 (27.3)
3 (13.6)
6 (27.3)
4 (18.2)
22 (23.2)
15 (15.8)
13 (13.7)
26 (27.4)
19 (20.0)
54 (15.2)
68 (19.2)
64 (18.0)
99 (27.9)
70 (19.7)
Ability to climb 2 flights  
of stairs
yes 
no
107 (89.2)
13 (10.8)
96 (85.7)
16 (11.9)
78 (78.8)
21 (21.2)
21 (95.5)
1 (4.5)
72 (75.0)
24 (25.0)
302 (85.6)
51 (14.4)
Physical fitness
excellent
good
average
poor 
very poor
5 (4.1)
50 (40.7)
53 (43.1)
14 (11.4)
1 (0.8)
9 (7.8)
46 (40.0)
46 (40.0)
13 (11.3)
1 (0.9)
5 (5.1)
38 (38.4)
37 (37.4)
18 (18.2)
1 (1.0)
2 (9.5)
7 (33.3)
6 (28.6)
5 (23.8)
1 (4.8)
2 (2.0)
38 (38.4)
37 (37.4)
20 (20.2)
2 (2.0)
21 (5.9)
141 (39.4)
142 (39.7)
50 (14.0)
4 (1.1)
Overall health
excellent
good
average
poor 
very poor
14 (10.9)
66 (51.2)
37 (28.7)
12 (9.3)
0 (0.0)
17 (13.8)
62 (50.4)
36 (29.3)
7 (5.7)
1 (0.8)
7 (6.9)
42 (41.2)
35 (34.3)
17 (16.7)
1 (1.0)
3 (14.3)
6 (28.6)
8 (38.1)
3 (14.3)
1 (4.8)
6 (5.9)
47 (46.1)
36 (35.3)
12 (11.8)
1 (1.0)
41 (10.9)
176 (46.9)
116 (30.9)
39 (10.4)
3 (0.8)
Cognitive function 
normal (TYM score ≥45)
diminished (TYM score <45)
88 (69.3)
39 (30.7)
84 (70.6)
35 (29.4)
47 (50.0)
47 (50.0)
17 (81.0)
4 (19.0)
48 (48.4)
45 (51.6)
236 (65.4)
125 (34.6)
TYM, Test Your Memory. Composite preoperative risk predictors (II)
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5.4.3 Composite preoperative risk predictors (II)
In	Study	II,	all	preoperative	variables	significantly	predicting	study	
outcome measures in univariable analyses underwent logistic 
regression analyses (for systemic and infectious complications) 
or	 linear	 regression	 analyses	 (for	 resource	 use).	 No	 significant	
associations were detectable between preoperative risk predictors 
and	new	CNS	deficits.	After	multivariable	analyses	for	systemic	and	
infectious complications, CRP dichotomized at >3 mg/l (p=0.049), 
age	dichotomized	at	≥60	years	(p=0.013),	and	Helsinki	ASA	score	
4	(p=0.016)	retained	their	statistical	significance.	The	AUC	for	this	
model was 0.766 (p<0.001, CI 0.673-0.869) (Figure 7). Helsinki ASA 
score	4	was	the	only	variable	that	remained	a	significant	predictor	
after multivariable analyses for both ICU (p=0.004) and hospital 
LOS (p=0.023). 
Combinations	of	variables	retaining	their	significance	after	the	
multivariable analyses were evaluated to identify patients at high risk 
for complications and increased resource use. The combination of 
Helsinki	ASA	score	4,	age	≥60	years,	and	preoperative	CRP	>3	mg/l	
identified	almost	one-fourth	of	patients	with	systemic	and	infectious	
complications (p=0.005, OR 4.8, CI 1.5-15.9, sensitivity 14.3%, 
specificity	96.7%,	PPV	23.5%,	NPV	94.0%)	(II).	The	combination	of	
Helsinki	ASA	score	4	and	age	≥60	years	was	associated	with	a	nearly	
40% increase in ICU LOS (p=0.018) and a 20% increase in hospital 
LOS (p=0.004) (II). 
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Figure 7. ROC curves for preoperative risk scores and multivariable logistic regression model 
(Study II) based on the current cohort in predicting systemic and infectious complications. 
ASA, American Society of Anesthesiologists
Score AUC 
Multivariable model 0.766
Score AUC 
ASA 0.609
Helsinki ASA 0.655
mRS  0.651
Charlson 0.642
Modified Rankin Scale
Charlson comorbidity score
Original ASA score
Helsinki ASA score
Reference line
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Reference line
1,0
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1,0
0,8
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5.5 Postoperative in-hospital assessments
5.5.1 mRS at hospital discharge (III)
A hospital discharge mRS score was available for 406 patients, 
including the 4 who died before discharge (mRS score 6). Respec-
tive mean and median hospital discharge mRS scores were 1.5 
(SD 1.5) and 1 (range 0-6). The distribution of postoperative mRS 
scores is presented in Figure 8. At hospital discharge, 314 (77.3%) 
of	all	patients	were	functionally	independent	(mRS	score	≤2).	The	
corresponding	numbers	were	74	(61.7%)	for	elderly	patients	(≥65	
years), 84 (71.2%) for patients with malignant tumors, 104 (78.8%) 
for those with benign tumors, and 106 (79.7%) for those undergoing 
cerebrovascular surgery.
Of individual major complications, mRS score at hospital dis-
charge	dichotomized	at	≥3	was	associated	with	new	or	worsened	
hemiparesis (p<0.001, OR 20.4, CI 9.0-46.4), silent stroke (p=0.003, 
OR 18.0, CI 2.1-156.0), AMI (p=0.003, OR and CI not calculable), and 
pneumonia (p<0.001, OR 51.5, CI 6.6-399.6). The rarity of individual 
complications resulted in very wide CIs, thus limiting the reliability of 
these associations. Of individual minor complications, meningitis/WI 
(p=0.031, OR 4.5, CI 1.2-16.9), minor infections (p=<0.001, OR 3.4, 
CI 1.7-6.7), and minor cranial reoperations in the OR (p=0.011, OR 
and	CI	not	calculable)	were	associated	with	mRS	score	≥3	at	hospital	
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discharge. The associations of hospital discharge mRS scores with 
study outcome measures are presented in Table 21. 
The	mRS-score	difference	from	preoperative	to	hospital	discharge	
score was available for 405 patients (Figure 9). The median mRS-
score	difference	was	0	(range	-2-6).	An	increase	in	mRS	score	(mRS-
score	difference	>0)	was	associated	with	the	following	complication	
phenotypes: hemiparesis (p=<0.001, OR 11.7, CI 5.0-27.2), silent 
stroke (p=0.008, OR 13.0, CI 1.5-112.2), pneumonia (p<0.001, OR 
and CI not calculable), SVD (p<0.001, OR 3.1, CI 1.7-5.6), and speech 
impairment (p=0.004, OR 3.3, CI 1.4-7.8).
At hospital discharge, 138 (34.1%) patients had an mRS-score 
difference	>0	and	54	(13.3%)	>1.	Of	216	patients	with	no	recorded	
short-term complications, their mRS score increased in 37 (17.1%). 
Of 75 patients with major complications, 21 (28.0%) showed no in-
crease in mRS scores at discharge. Furthermore, of these 75 patients, 
41	(54.6%)	had	no	mRS-score	difference	>	1	at	discharge.	Only	57.6	
%	of	all	patients	with	mRS	score	≥3	at	discharge	experienced	major	
morbidity.	Significant	associations	were	detectable	between	study	
outcome	measures	and	mRS-score	difference	>0	at	discharge	(Table	
21).
Figure 8. Distribution of mRS scores at hospital discharge
mRS score at 
hospital discharge
Patients (%)
N=406
0 147 (36.2)
1 91 (22.4)
2 76 (18.7)
3 40 (9.9)
4 36 (8.9)
5 12 (2.9)
6 4 (1.0)
Number of patients
mRS scores at hospital discharge
0  1  2  3  4  5  6
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150
100
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0
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5.5.2 Postoperative patient-reported outcomes (V)
Table 20 presents the postoperative patient-reported outcomes for 
all study patients, indication subgroups, and the elderly. At hospital 
discharge, 317 (75.8%) patients reported their subjective functional 
status.  Of 308 (73.7%) patients with available postoperative TYM 
scores, 238 (77.3%) had normal cognition. Subjective deterioration 
in	functional	status	was	associated	with	30-day	mRS	≥3	indicating	
dependent functional status (p<0.001, OR 3.1, CI 1.6-5.8). 
Both subjective deterioration in functional status (p<0.001, OR 
18.1,	CI	5.3-61.6,	sensitivity	88.9%,	specificity	69.3%)	and	postop-
eratively diminished cognitive status (p<0.001, OR 4.3, CI 1.8-10.2, 
sensitivity	52.2%,	specificity	79.6%)	were	associated	with	new	CNS	
deficits	but	not	with	systemic	and	infectious	complications.
Of 103 patients who reported postoperative subjective deteriora-
tion in functional status, major morbidity occurred in 30 (26.5%), 
whereas the corresponding percentage was only 5.9 when subjective 
functional status remained unchanged or improved. The association 
between major morbidity and subjective deterioration in functional 
status	was	significant	in	univariable	analysis	(p<0.001,	OR	5.8,	CI	
2.8-11.8).	Furthermore,	this	association	remained	significant	after	
multivariable logistic regression analysis including all hospital dis-
mRS-score difference 
between preoperative and 
hospital discharge score
Patients (%)
N=405
-2 28 (6.9)
-1 90 (22.2)
0 149 (36.8)
1 84 (20.7)
2 28 (6.9)
3 16 (4.0)
4 8 (2.0)
5 1 (0.2)
6 1 (0.2)
Figure 9. Distribution of mRS-score differences between preoperative and hospital discharge score.
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charge and 30-day PROs (p=0.001, OR 4.9, CI 1.9-12.0, sensitivity 
71.4%,	and	specificity	69.8%).	In	patients	aged	≥65,	major	morbidity	
complicated the outcome in 10 of 18 patients with postoperative 
subjective deterioration in functional status (sensitivity 71.4%, spec-
ificity	74.6%).	The	association	between	postoperatively	diminished	
cognitive	status	and	major	morbidity	was	also	significant	in	univari-
able analysis (p=0.009, OR 2.5, CI 1.2-5.2), but not in multivariable 
logistic regression analysis. 
Both postoperative subjective deterioration in functional status 
(p<0.001, OR 7.3, CI 4.3-12.3) and postoperatively diminished cog-
nitive status (p=0.015, OR 1.9, CI 1.1-3.3) were associated with overall 
morbidity, but after multivariable logistic regression analysis only the 
association between postoperative subjective deterioration in func-
tional	status	and	overall	morbidity	remained	significant	(p<0.001,	
OR	5.7,	CI	3.1-10.7,	sensitivity	58.6%,	specificity	83.7%).	
Table 20. Postoperative and 30-day patient-reported outcomes
Variables
Vascular 
lesion
Patients (%)
Benign 
tumor
Patients (%)
Malignant 
tumor
Patients (%)
Other
Patients (%)
Age ≥65 
years
Patients (%)
All
Patients (%)
Change in functional status*
unchanged
better
worse
74 (66.7)
4 (3.6)
33 (29.7)
48 (44.9)
16 (15.0)
43 (40.2)
24 (31.2)
21 (27.3)
32 (41.6)
7 (31.8)
10 (41.7)
5 (22.7)
37 (43.5)
20 (23.5)
28 (32.9)
145 (48.3)
51 (16.2)
113 (35.6)
Cognitive function*
normal (TYM score ≥45)
diminished (TYM score <45)
88 (63.8)
22 (15.9)
82 (79.6)
21 (20.4)
50 (68.5)
23 (31.5)
18 (81.8)
4 (18.2)
52 (62.7)
31 (37.3)
238 (77.3)
70 (22.7)
Symptom severity†
none
mild
severe
43 (32.1)
66 (49.3)
25 (18.7)
35 (27.3)
47 (36.7)
46 (35.9)
39 (34.8)
32 (28.6)
41 (36.6)
10 (41.7)
8 (33.3)
6 (25.0)
31 (28.2)
47 (42.7)
32 (29.1)
127 (31.9)
153 (38.4)
118 (29.6)
Subjective overall health† 
excellent
good 
average
poor 
very poor
5 (4.4)
48 (42.5)
47 (41.6)
9 (8.0)
4 (2.9)
13 (12.7)
47 (46.1)
34 (33.3)
7 (6.9)
1 (1.0)
7 (6.9)
38 (37.6)
37 (36.6)
14 (13.9)
5 (5.0)
2 (8.3)
16 (66.7)
6 (25.0)
0 (0.0)
0 (0.0)
9 (9.4)
41 (42.7)
31 (32.3)
11 (11.5)
4 (4.2)
27 (7.9)
149 (43.8)
124 (36.5)
30 (8.8)
10 (2.9)
Overall satisfaction†
excellent
good
satisfactory
poor
very poor
64 (56.6)
42 (37.2)
5 (4.4)
1 (0.9)
1 (0.9)
64 (62.7)
34 (33.3)
3 (2.9)
1 (1.0)
0 (0.0)
56 (55.4)
35 (34.7)
9 (8.9)
1 (1.0)
0 (0.0)
15 (62.5)
9 (37.5)
0 (0.0)
0 (0.0)
0 (0.0)
53 (55.2)
38 (39.6)
5 (5.2)
0 (0.0)
0 (0.0)
199 (58.5)
120 (35.3)
17 (5.0)
3 (0.9)
1 (0.3)
*at hospital discharge 
†at 30 days.
TYM, Test Your Memory. 
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5.6 30-day follow-up assessments
5.6.1 mRS at 30 days (III)
The 30-day mRS scores were available for 350 patients, including 
those who died during the follow-up (mRS score 6) (Figure 10). The 
mean and median mRS scores at 30 days were 1.4 (SD 1.5) and 1 
(range 0-6), respectively. In univariable analyses, major complica-
tions	associated	with	30-day	mRS	score	≥3	indicating	dependent	
functional status comprised new or worsened hemiparesis (p=0.001, 
OR 3.4, CI 1.6-7.4), silent stroke (p=0.003, OR and CI not calculable), 
and pneumonia (p<0.001, OR 24.5, CI 3.0-202.2). Of individual mi-
nor complications, minor infections (p=0.048, OR 2.2, CI 1.0-4.8), 
and subjective visual disturbances (p=0.002, OR 2.4, CI 1.4-4.4) 
were	associated	with	high	30-day	mRS	score	(≥3).	The	associations	
between	30-day	mRS	score	≥3	and	study	outcome	measures	are	in	
Table 21. 
The	mRS-score	difference	 from	preoperative	 to	 30-day	 score	
was available for 349 patients (Figure 11). The median mRS-score 
difference	was	0	(range	-4-6).	An	mRS-score	increase	(mRS-score	dif-
ference >0) at 30 days was associated with complication phenotypes 
hemiparesis (p<0.026, OR 2.3, CI .1-5.1), silent stroke (p=0.013, 
OR and CI not calculable), pneumonia (p=0.012, OR and CI not 
calculable), SVD (p=0.027, OR 2.0, CI 1.1-3.6), and minor infection 
(p=0.043, OR 2.9, CI 1.1-8.2). 
Of	the	349	patients,	126	(36.1%)	patients	had	mRS-score	differ-
ences >0 and 57 (16.3%) >1. Almost one-third (31.2%) with good 
preoperative functional status (mRS score 0-1) and no reported post-
operative	complications	had	an	mRS-difference	>0	at	30	days.	The	
mRS scores did not increase from preoperative to 30 days (mRS-score 
difference	≤0)	in	46.2%	of	patients	in	the	same	subgroup	(preopera-
tive mRS 0-1) despite recorded major complications. An increase in 
mRS	score	at	30	days	(mRS-score	difference	>0)	was	associated	with	
the study outcome measures (Table 21). 
The mRS scores decreased in 101 (28.9%) and remained un-
changed in 122 (35.0%) from hospital discharge to 30 days. Of 
these 349 patients, 189 had no recorded short-term postoperative 
complications, yet their mRS scores increased for 45 (23.8%) such 
patients at 30 days.
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mRS, modified Rankin Scale
Number of patients
mRS scores at 30 days
0  1  2  3  4  5  6
120
100
80
60
40
20
0
mRS score at 30 days
Patients (%) 
N=350
0 110 (31.4)
1 111 (31.7)
2 46 (13.1)
3 56 (16.0)
4 11 (3.1)
5 6 (1.7)
6 10 (2.9)
Figure 10. Distribution of mRS scores at 30 days.
Figure 11. Distribution of mRS-score differences from preoperative to 30-day scores.
mRS, modified Rankin Scale
Number of patients
mRS-score difference from admission to 30 days
0 1 2 3 4 5 6
120
100
80
60
40
20
0
–4 –3 –2 –1 
mRS-score difference 
from preoperative to 
30-day score
Patients (%)
N=349
-4 1 (0.3)
-3 3 (0.9)
-2 31 (8.9)
-1 66 (18.9)
0 122 (35.0)
1 69 (19.8)
2 36 (10.3)
3 16 (4.6)
4 2 (0.6)
5 2 (0.6)
6 1 (0.2)
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Table 21. Associations of hospital discharge and 30-day follow-up assessments with study 
outcome measures. Significant associations in bold, Fisher’ Exact test results italicized.
New CNS deficits
p OR 95% CI sensitivity (%) specificity (%)
mRS score ≥3 at discharge† <0.001 22.8 10.4-49.9 80.4 84.7
mRS-score difference  
at discharge >0†
<0.001 12.3 5.5-27.3 82.6 72.1
mRS score ≥3 at 30 days‡ <0.001 4.7 2.2-9.7 54.5 79.5
mRS-score difference >0  
at 30 days‡‡
0.002 3.0 1.5-6.4 60.6 66.5
Low overall patient 
satisfaction**
0.414 1.8 0.5-6.5 10.0 94.2
SI complications
p OR 95% CI sensitivity (%) specificity (%)
mRS score ≥3 at discharge§ <0.001 16.1 6.3-41.3 78.6 81.5
mRS-score difference  
at discharge >0†
<0.001 10.5 3.9-28.3 82.1 69.5
mRS score ≥3 at 30 days‡ <0.001 8.2 3.2-20.9 68.2 79.3
mRS-score difference >0  
at 30 days‡‡
<0.001 5.2 2..0-13.8 72.7 66.4
Low overall patient 
satisfaction**
0.079 3.6 1.0-13.8 17.6 94.4
Major morbidity
p OR 95% CI sensitivity (%) specificity (%)
mRS score ≥3 at 
discharge†
<0.001 18.0 9.9-32.8 70.7 88.2
mRS-score difference at 
discharge >0†
<0.001 7.5 4.3-13.2 72.0 74.5
mRS score ≥3 at 30 days‡ <0.001 6.0 3.3-11.1 56.4 82.4
mRS-score difference >0 
at 30 days‡‡
<0.001 3.9 2.1-7.1 63.6 69.0
Low overall patient 
satisfaction**
0.054 2.7 1.0-7.4 12.8 94.9
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Overall morbidity
p OR 95% CI sensitivity (%) specificity (%)
mRS score ≥3 at 
discharge§
<0.001 6.0 3.5-10.5 38.1 90.8
mRS-score difference at 
discharge >0†
<0.001 5.5 3.5-8.8 53.4 82.9
mRS score ≥3 at 30 days‡ <0.001 3.8 2.2-6.4 36.3 61.8
mRS-score difference >0 
at 30 days‡‡
<0.001 3.3 2.1-5.2 50.6 76.2
Low overall patient 
satisfaction**
0.215 1.7 0.7-4.3 8.0 95.3
*n=414, †n=405, ‡n=350, ‡‡n=349, **n=340, §n=406
CI, confidence interval; CNS, central nervous system; mRS, modified Rankin Scale; N/A, not applicable; OR, odds 
ratio; SI, systemic and infectious. 
5.6.2 Patient-reported outcomes at 30 days and composite  
 scores of postoperative patient-reported outcomes (V)
A total of 340 (81.3%) patients answered the 30-day structured 
telephone interview. The 30-day patient-reported outcomes in all 
study patients, indication subgroups, and the elderly are in Table 20. 
Overall health status at 30 days was available for 340 (81.3%) pa-
tients, and 88.2% of them reported good overall health. Poor overall 
health status was associated with dependent functional status (mRS 
score	≥3)	at	30	days	(p<0.001,	OR	11.5,	CI	5.5-23.9).	
Poor overall health status at 30 days as associated with new CNS 
deficits	(p=0.004,	OR	3.8,	CI	1.6-9.2,	sensitivity	30.0%,	specificity	
90.0%) but not with systemic and infectious complications.
Major morbidity was recorded in 13 (32.5%) of 40 patients and 
overall morbidity in 58 (69.9%) of 83 patients with poor overall health 
status at 30 days. In univariable analyses, the associations between 
poor overall health status and both major morbidity (p<0.001, OR 
3.7,	 CI	 1.8-8.0,	 sensitivity	 27.7%,	 specificity	 90.8%)	 and	 overall	
morbidity	(p=0.002,	OR	3.0,	CI	1.5-6.0,	sensitivity	18.0%,	specificity	
93.2%)	were	significant.	Both	associations	lost	their	significance	after	
multivariable logistic regression analysis. 
In	elderly	patients	 (age	≥65),	 a	 combination	of	postoperative	
subjective deterioration in functional status and poor overall health 
status	was	recorded	in	8	patients,	5	of	whom	suffered	major	morbidity	
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(sensitivity	45.5%,	specificity	95.5%),	and	all	of	whom	suffered	overall	
morbidity	(sensitivity	22.2%,	specificity	100.o%).	
To build a simple, unweighted composite score, i.e. preliminary 
PROM,	we	identified	264	(63.2%)	patients	for	whom	all	three	post-
operative PROs recorded in this study (postoperative subjective 
functional status at discharge, postoperative TYM score at discharge, 
and overall health status at 30 days) were available. Postoperative de-
terioration in functional status, postoperatively diminished cognitive 
function, and poor overall health status each yielded one point in the 
score	ranging	from	0	to	3.	A	composite	score	≥1	point	was	associat-
ed with major morbidity (p<0.001, OR 7.7, CI 2.6-22.8, sensitivity 
71.7%,	specificity	67.4%)	and	overall	morbidity	(p>0.001,	OR	5.2,	CI	
3.1-8.8,	sensitivity	86.7%,	specificity	54.3%).	A	high	composite	score	
(3) was also associated with both major morbidity (p<0.001, OR 11.4, 
CI	3.3-40.3,	sensitivity	8.3%,	specificity	99.3%)	and	overall	morbidity	
(p=0.003,	OR	13.0,	CI	1.6-103.1,	sensitivity	20.0%,	specificity	97.9%).
5.6.3 Patient satisfaction at 30 days (IV)
Patient satisfaction was available for 340 (81.3%) patients. Table 20 
presents the distribution of patient satisfaction scores in indication 
subgroups and for elderly patients. 
Patient satisfaction in our cohort was high: 93.8% patients rated 
their overall satisfaction as excellent or good. Poor satisfaction was 
the response of 3 (0.9%) patients and very poor satisfaction of only 
1 (0.3%) (Table 22). 
Table 22. Distribution of patient satisfaction scores in all patients 
and in patients with major and overall morbidity. 
Patient satisfaction, n (%)
Group (patients) very poor poor satisfactory good excellent
All (340) 1 (0.3) 3 (0.9) 17 (5.0) 120 (35.3) 199 (58.5)
Major 
morbidity (47)
1 (2.1) 1 (2.1) 4 (8.5) 20 (42.6) 21 (44.7)
Overall
morbidity (150)
1 (0.7) 3 (2.0) 8 (5.3) 63 (42.0) 75 (50.0)
Altogether 47 patients for whom satisfaction ratings were available 
experienced major morbidity, however, 42 (89.4%) of them reported 
high satisfaction (Table 23). 
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Of	the	19	variables,	only	30-day	mRS	score	≥3	
(p<0.001, OR 5.6, CI 2.3-14.0), minor infections 
(p=0.006, OR 4.9, CI 1.7-13.8), poor subjective 
overall health status at 30 days (p=0.001, OR 
5.5, CI 2.1-14.3), and severe subjective symptoms 
at 30 days (p=0.038, OR 2.7, CI 1.1-6.6) asso-
ciated with low overall satisfaction at 30 days. 
In a subgroup analysis, patients with dependent 
functional status at 30 days were older (p<0.001) 
and more likely already functionally dependent 
preoperatively (p<0.001). Furthermore, they 
had higher preoperative ASA scores (p=0.02), Helsinki ASA scores 
(p<0.001), and Charlson comorbidity scores (p=0.002), and longer 
hospital LOS (p<0.001). This subgroup, in comparison with the whole 
cohort, also had a higher proportion of malignant tumors (55.4% 
versus 22.8%, p<.001, OR 4.2, CI 2.5-7.1) and a lower proportion of 
benign tumors (18.1% versus 34.1%, p=.006, OR 0.4, CI 0.2-0.8).
Table 23. Patient satisfaction in outcome subgroups. Numbers of patients.
Outcome Patients
Satisfaction 
available
High overall 
satisfaction (%) 
Unplanned re-CRT or EI 17 13 11 (84.6)
Functionally dependent (mRS score ≥3) 
at hospital discharge
at 30 days
92
83
56
73
49 (87.5)
61 (83.6)
Subjective overall health at 30 days
poor
good
40
300
40
300
32 (80.0)
287 (95.7)
Subjective symptoms at 30 days
mild
severe
139
90
139
90
130 (93.5)
80 (88.9)
CRT, craniotomy; EI, endovascular intervention; mRS, modified Rankin Scale.
Low	overall	satisfaction	showed	no	association	with	new	CNS	deficits,	
systemic and infectious complications, major morbidity, or overall 
morbidity (Table 21). Patients with low overall satisfaction had a 
longer hospital LOS than did those with high satisfaction (p=0.001, 
mean 7.2 versus 5.2 days, median 6.0 versus 4.0 days).
MR image suggesting an aneurysm of the middle 
cerebral artery.   
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6. DISCUSSION
6.1 Preoperative risk-assessment methods
Evidence for the use of preoperative risk-assessment methods in 
elective cranial neurosurgery is scarce. Compared to another category 
of major surgery, cardiac surgery, the number of studies published in 
neurosurgery is still modest; more than 300 articles on preoperative 
risk-assessment methods in cardiac surgery appeared in 2011 alone, 
whereas in Study I the number of relevant neurosurgical studies 
since 1980 came only to 25. Furthermore, none of the articles were 
reports on an unselected consecutive series of elective craniotomy 
patients, only four of the studies were prospective, and cohort sizes 
were generally small, with less than 100 patients in one-third of the 
studies included. Those studies with large patient cohorts (>1000 
patients) were all retrospective and register-based, thus displaying 
the inevitable weaknesses associated with such a design: inaccuracy 
of patient sampling (often selection by CPT codes), lack of detailed 
preoperative data, and variable but limited rates and types of com-
plications. Neurosurgical centers have yet to widely implement 
proposed methods of classifying complications after neurosurgical 
procedures.156 Direct comparisons and risk calculations were impos-
sible	due	to	considerable	differences	in	assessment	methods,	study	
settings, and reporting principles.
Many preoperative risk-assessment scores and models have been 
proposed for cranial neurosurgery, even ones including intraoperative 
variables; these scores and models, in a preoperative context, provide 
merely an estimate based on little more than educated guesswork 
or statistical means.102 These scores were excluded from Study I, 
based on our search protocol. It can be argued whether these can be 
considered truly preoperative scores, and, at the very least, clinicians 
should	recognize	this	difference.
Patient characteristics and laboratory measurements
Few preoperatively recorded patient characteristics and laboratory 
measurements were associated with adverse outcome in Study II. 
More	specifically,	no	associations	were	detectable	between	individual	
preoperative variables and CNS complications. Furthermore, none 
of the preoperative patient characteristics or laboratory measure-
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ments	remained	significant	predictors	for	the	length	of	ICU	stay	or	
hospital stay after multivariable analyses. Only advanced age and 
preoperatively elevated CRP were independent predictors of systemic 
and infectious complications after multivariable logistic regression 
analyses. (II) Judging by neurological outcome and resource use only, 
the role of preoperative patient characteristics and especially routine 
laboratory measurements is questionable; however, non-neurological 
major complications may still justify the use of such measurements 
as one risk-assessment tool to improve patient safety.
Reports on the impact of age on outcome of patients with in-
tracranial malignancies have been predominantly negative,83, 93, 
99	but	the	opposite	findings	have	also	emerged.92 It is noteworthy 
that interpreting these results may be confounded by the markedly 
reduced	survival	reported	for	elderly	patients	suffering	from	malig-
nant intracranial tumors.157 Study II showed that the rates of major 
(25.6% versus 28.9%) or overall (45.5% versus 48.9%) morbidity 
were very similar in all study patients and in elderly patients. In the 
vascular intracranial surgery group as well, both positive and negative 
findings	exist	on	the	role	of	advanced	age	as	a	predictor	of	adverse	
surgical outcome.85, 96, 101 Our results in Study II imply that overall 
morbidity was higher in elderly patients than in the overall cohort 
(51.6% vs 46.4%) and the rate of major morbidity was nearly double 
that in elderly craniovascular surgery patients (20.7% versus 10.9%), 
suggesting that age should be taken into consideration when mak-
ing patient-centered treatment decisions, especially in intracranial 
vascular patients.  
The results of Study II suggest that the predictive value of in-
dividual preoperative laboratory measurements is low. This is in 
keeping with international recommendations discouraging the 
use of routine screening tests.63 Only preoperatively elevated CRP 
retained	its	significance	after	multivariable	analysis	in	Study	II	as	
an independent predictor of systemic and infectious complications. 
No previous reports on such association exist. Further studies are 
necessary	to	confirm	the	role	of	CRP	in	preoperative	risk	prediction,	
but the biological rationale behind the association of preoperatively 
elevated CRP indicating an acute phase reaction with postoperative 
systemic and infectious complications is sound.
Low preoperative hemoglobin level was associated with silent 
stroke but not with any other individual complication or composite 
morbidity. This may indicate that oxygen delivery to parts of the brain 
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may	be	insufficient	or	compromised	in	patients	with	preoperatively	
low	hemoglobin	which	may	be	further	diluted	by	perioperative	fluid	
therapy, especially mannitol or hypertonic saline. Contradictory re-
ports	on	the	effect	of	preoperative	anemia	on	postoperative	outcome	
in elective cranial neurosurgery have recently appeared.158, 159 Alan et 
al. detected an association between preoperative anemia and pro-
longed hospitalization and increased resource use in a large NSQIP 
database cohort;158	our	results	support	this	finding	with	a	significant	
association between extended hospital stay and low preoperative Hb. 
Thus, an active approach to preoperative anemia treatment may be 
advisable.
ASA score 
Study I showed that evidence supports use of the ASA score in 
predicting overall morbidity82, 83 and nonsurgical (systemic and 
infectious)114, 115 adverse outcomes in elective cranial neurosurgery, 
especially in patients with intracranial tumors. It should be noted 
that	the	criteria	for	ASA	Physical	Status	Classification	scores	were	not	
explicitly	defined	in	the	articles,	and	given	the	considerable	interrater	
variability and national/institutional variation associated with this 
scale, interpretation of such results should be cautious. Study II 
results suggest that in an unselected cohort of elective craniotomy 
patients,	the	original	ASA	score	could	predict	neither	CNS	deficits,	
systemic or infectious complications, nor resource use (ICU/hospital 
LOS). Of major complications, high preoperative ASA score predicted 
only	AMI.	Thus,	evidence	for	use	of	the	original	ASA	classification	
score for preoperative risk assessment of elective craniotomy patients 
is not compelling.
Helsinki ASA score and composite preoperative  
risk predictors
Study II validated Helsinki ASA score 4 as an independent predictor 
of	systemic	and	infectious	complications	(sensitivity	32%,	specificity	
85%, PPV 13%, and NPV 95%) as well as of increased resource use 
after multivariable regression analyses. Our results indicate that the 
modification	provides	a	tailored	risk-assessment	scale	for	the	unique	
patient	mix	and	complications	profile	in	elective	cranial	neurosurgery.	
The	Helsinki	modification	of	the	ASA	Physical	Status	Classification	
has received no earlier validation despite having been in clinical use 
for decades. Compared to the original ASA score, the Helsinki ASA 
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score seemed more accurate in predicting systemic and infectious 
complications. The Helsinki ASA score, however, is subject to the 
same concerns related to interrater variability as the original ASA 
score. It should be noted that Helsinki ASA scores failed to predict 
surgical	outcomes	(new	CNS	deficits)	and	thus	should	probably	not	
serve as the sole risk-assessment method for elective craniotomy 
patients.
The composite preoperative risk predictor in Study II comprised 
preoperative Helsinki ASA score 4, preoperative CRP over 3 mg/l, and 
age	60	years	or	over.	This	combination	identified	almost	one	in	four	
patients with postoperative systemic and infectious complications. 
A combination of Helsinki ASA score 4 and age 60 years or over was 
associated with a nearly 40% increase in ICU LOS and 20% increase 
in hospital LOS. These simple composites of simple preoperative 
variables can easily be implemented in clinical practice to support 
patient-centered decision-making, even in the hectic setting of a 
preoperative clinic at a tertiary neurosurgical center. 
According to these results, the value of the Helsinki ASA may 
be further enhanced in combination with other predictors. Future 
studies are needed to develop and validate a tailored risk-assessment 
score for elective cranial neurosurgery, with Helsinki ASA a possible 
component for such a composite score.
The mRS score
In our prospective cohort, a preoperatively dependent functional 
status	(mRS	score	≥3)	predicted	both	new	CNS	deficits	(sensitivity	
19.1%,	specificity		90.8%,	PPV	20.9%,	NPV	89.8%)	and	systemic	and	
infectious complications in univariable analyses, with slightly lower 
sensitivity (25.0% versus 32.1%) and a slightly higher PPV (16.3% 
versus 13.2%), compared to the Helsinki ASA score 4. (Reponen et 
al., unpublished data)
We recorded preoperative mRS scores primarily to determine the 
mRS-score	differences	between	preoperative	(baseline),	hospital	dis-
charge, and 30-day follow-up time-points. Preoperative mRS scores 
have, however, been proposed as a preoperative risk-assessment 
method for elective craniotomy patients: two studies assessing the 
applicability of mRS in such a context were included in Study I.96, 97 
Both were retrospective, included patients undergoing intracranial 
vascular surgery, and had surgery-related outcomes; their results 
were contradictory. 
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Our	findings	(Reponen	et	al.,	unpublished	data)	are	in	concor-
dance with the results of Study I, in which the KPS, another scale for 
measuring functional status, received the most support for use as a 
preoperative risk-assessment scale in elective cranial neurosurgery. 
The mRS score may prove useful for preoperative risk assessment for 
postoperative	CNS	deficits	of	patients	undergoing	vascular	intracra-
nial	surgery,	but	large	prospective	studies	are	necessary	to	confirm	
its applicability to such a use. 
The Charlson comorbidity score
In	our	cohort,	a	high	preoperative	Charlson	comorbidity	score	(≥3)	
was associated with systemic and infectious complications. (Reponen 
et al., unpublished data). 
In Study I, three large retrospective studies assessed the appli-
cability of the Charlson Comorbidity score.99-101 In keeping with our 
results, evidence supported the use of the Charlson comorbidity 
score in predicting risk for morbidity and mortality in patients with 
intracranial tumors (both benign100 and malignant99), and mortality 
in intracranial vascular surgery patients.101 In a very recent retrospec-
tive study on patients with glioblastoma, the Charlson comorbidity 
index	(a	later	age-corrected	modification	of	the	Charlson	comorbidity	
score)	proved	beneficial	in	preoperative	patient	stratification.160 The 
retrospective design and the inclusion of emergency patients com-
plicates	comparison	of	our	results	with	these	previous	findings,	but	
the Charlson comorbidity score may be an asset in preoperative risk 
assessment of elective craniotomy patients.
Directions for risk stratification in elective neurosurgery
The Helsinki ASA score had a good AUC (0.81) for mortality, superior 
to AUCs for all other risk-assessment scores we assessed. In fact, this 
figure	is	very	similar	to	the	reported	AUCs	of	the	Euroscore	I	(0.77-
0.84),161, 162 and Euroscore II (0.77-0.85),161-164 for mortality in cardiac 
surgery patients. The reported AUCs of POSSUM for mortality in 
gastroenterological surgery patients range from 0.62 to 0.80,165, 166 
and those of P-POSSUM from 0.70 to 0.80.165, 167 Mortality is too crude 
a measurement of outcome in modern neurosurgery, but AUCs of the 
existing scores for all other study outcome measures in our cohort 
were poor. Our multivariable logistic regression model was able to 
provide a higher AUC, but still left room for improvement.
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It	is	evident	that	none	of	the	existing	risk-assessment	scores	fulfills	
the	criteria	for	a	neurosurgery-specific	risk-stratification	tool.	It	is	
surprising that this important topic has received very little attention 
in neurosurgery, unlike in cardiac surgery, where active research in 
the	field	has	enabled	development	of	a	tailored	risk-assessment	score	
widely adopted for clinical use, the EuroSCORE. 
6.2 Outcomes and outcome reporting
Currently, no consensus exists on outcome reporting in elective cra-
nial neurosurgery. This was especially evident in Study I, in which 
outcomes had to be categorized in four broad categories to allow 
for	any	summarization	of	the	results.	Traditionally,	the	definition	
of	surgical	outcome	has	been	simply	new	or	worsened	CNS	deficits,	
but as the focus has turned to patient safety and quality of care, other 
adverse events, such as systemic and infectious complications, are 
increasingly included among outcomes. Furthermore, any appropri-
ate	outcome	measure	should	be	defined	by	the	time-point	at	which	
it is measured –if complications attributable primarily to surgical 
intervention are of interest, the outcomes should be reported soon 
after surgery, before disease progression, further treatment, or other 
confounding factors blur the results.
In Studies III, IV, and V, the rate of major morbidity including 
in-hospital mortality was 18.2%. To obtain as complete complica-
tion data as possible we used three data sources: patient-reported 
questionnaires, study forms, and hospital databases. Even transient 
hemiparesis was included in major morbidity which can be con-
sidered a low percentage for surgery on the most delicate and vital 
organ, the brain. Morbidity rates in large retrospective database 
studies range from 15.8% to 23.6%, but direct comparisons with our 
results are impossible due to data-collection issues and reliability of 
data.	Our	results	may	perhaps	be	considered	as	the	first	prospective	
benchmarking	figures	for	high-volume	neurosurgical	centers.	
In Study II, the rate of systemic and infectious complications was 
6.7%. The only two studies on short-term outcome in an unselected 
cohort of craniotomy patients reported only systemic and infectious 
complications. According to Buang and Haspani, surgical-site in-
fections were reported in 7.7% of craniotomy patients, the major-
ity (63.1%) of whom underwent emergency surgery. Kourbeti and 
coworkers reported a rate of 5.5% for meningitis in a retrospective 
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cohort comprising both elective and emergency craniotomy patients. 
We reported a wider range of systemic and infectious complications, 
but	our	results	are	in	close	agreement	with	the	earlier	figures.	
In our cohort, the rate of major complications in the subgroup of 
patients	aged	≥65	was	25.0%	and	of	overall	complications,	51.6%.	
These	are	in	agreement	with	reported	morbidity	figures	of	9%	to	
54% for elderly patients undergoing intracranial surgery for benign 
tumors.75, 78, 84, 168-178 Again, direct comparisons of morbidity rates are, 
however, impossible due to the extremely variable methodologies and 
definitions	employed	across	studies.
In our cohort (Studies II-V), the rate of in-hospital mortality was 
1.0%, and 30-day mortality was 2.4%. Reported short-term mortal-
ity rates for cranial neurosurgery range from 0.0% to 23.0%,75, 80-83, 
86, 88-94, 101, 114, 115	and	our	low	figures	support	the	view	that	mortality	
alone is an unsuitable outcome measure for modern elective cranial 
neurosurgery.
The mRS and outcome
Study	III	showed	that	despite	significant	associations	between	both	
high	mRS	score	(≥3)	at	discharge	and	mRS-score	difference	>0	at	
discharge	and	major/overall	morbidity,	the	mRS	is	a	poor	reflector	
of	short-term	outcome;	the	neurosurgical	community	could	benefit	
from	a	more	refined	outcome-reporting	tool.	
The mRS is probably the most widely used score for outcome 
reporting in elective cranial neurosurgery despite its never having 
received proper validation for such use. This widespread use is high-
lighted	by	the	most	influential	studies	in	cerebrovascular	surgery,	
including	the	first	randomized	treatment	trial	regarding	unruptured	
brain arteriovenous malformations (ARUBA),18 the International 
Study of Unruptured Intracranial Aneurysms (ISUIA),19 and the 
International Subarachnoid Aneurysm Trial (ISAT).16, 17, 20 
The	mRS	 score	has	 been	 conventionally	 dichotomized	 at	≥3,	
indicating a dependent functional status. Due to improvements 
in neurosurgical care and surgical techniques during the past few 
decades, however, nowadays only a small percentage of patients 
suffer	from	complications	sufficiently	severe	for	a	postoperative	mRS	
score	≥3.	In	Study	III,	one	in	five	cerebrovascular	patients	and	one	
in	four	intracranial	tumor	patients	had	an	mRS	score	≥3	at	hospital	
discharge.	Of	these	patients,	35%	already	had	an	mRS	score	≥3	at	
baseline	(preoperatively),	and	only	58%	had	suffered	major	complica-
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tions. Thus, a simple dichotomy seems unable to represent individual 
complications or even composite outcomes in modern neurosurgery. 
The	mRS-score	differences	behave	unpredictably	with	regard	to	
postoperative	complications:	Nearly	one	in	five	patients	at	hospital	
discharge and one in four at 30 days had an increased mRS score 
in the absence of any reported complications. Conversely, no mRS-
score increase at hospital discharge was detectable in 28% of those 
patients with major complications. In the subgroup of patients with 
good preoperative functional status (mRS score 0-1) and no reported 
complications, 31% had increased mRS scores at discharge. In the 
same subgroup (preoperative mRS score 0-1), no increase in mRS 
score at 30 days was detectable despite major complications in 46% 
of patients. 
Study III showed that after multivariable logistic regression analy-
sis, only new or worsened hemiparesis, silent stroke, and pneumonia, 
among	individual	complications,	remained	significantly	associated	
with an mRS score increase >2 at discharge. Despite these associa-
tions, the mRS seems a poor surrogate for overall outcome in elective 
cranial neurosurgery, and future studies must validate a more reliable 
tool.
PROs and composite score of PROs
Studying the applicability of validated PROMs in cranial neurosurgery 
was beyond the scope of this study. Study V results show, however, 
that even simple PROs or their combinations may be useful for out-
come reporting in elective cranial neurosurgery. In Study III, mRS 
was not an optimal outcome measure after elective craniotomy; in 
fact patient-reported postoperative deterioration in functional status 
was	more	sensitive	than	dependent	functional	status	(mRS	≥3)	for	
major morbidity (71.4% versus 56.4%) and overall morbidity (58.6% 
vs	36.6%).	In	the	subgroup	of	≥65-year-olds,	a	growing	subgroup	in	
cranial neurosurgery, a simple combination of postoperative deteri-
oration in functional status and poor overall health status at 30 days 
was	highly	specific	for	major	(95.5%)	and	overall	morbidity	(100.0%).	
In a very recent prospective study on a cohort of 191 brain tumor 
patients, Drewes and coworkers found that retrospective reviewing 
of patient records, a common method for reporting postoperative 
adverse events in neurosurgical centers, greatly underestimates the 
rate	of	new	or	worsened	neurological	deficits,	especially	cognitive	
problems, when compared with 30-day PROs.135 In agreement with 
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this, Study V results indicate that improving patient safety with the 
aid of direct patient input need not be complicated, a concern ex-
pressed by Varagunam and coworkers.179	Additional	benefits	include	
the absence of observer bias and inter-rater variability associated with 
conventional scores.25, 26, 28, 32 
The full potential of PROs is best realized in composites scores 
or PROMs. Validated PROMs may reduce the impact of diverging 
methods of outcome assessment in neurosurgical centers around 
the world. Recent reports by Schiavolin and coworkers show that 
established PROMs are valid and applicable also in neurosurgical 
patients.133, 141	In	concordance	with	this	and	the	findings	of	Drewer	
and coworkers,135 Study V showed that, depending on the chosen 
cutoff	value,	even	a	simple,	unweighted	composite	score	of	three	
PROs can improve outcome reporting by providing high sensitivity 
and	specificity	for	both	major	and	overall	morbidity.
6.3 Patient satisfaction
Study IV showed overall patient satisfaction in elective cranial 
neurosurgery to be high, with 93.8% of patients reporting good or 
excellent satisfaction in a 30-day follow-up telephone interview. Fur-
thermore, nearly 90% of patients with major complications reported 
high	overall	satisfaction,	and	no	association	was	identifiable	between	
low overall patient satisfaction and postoperative major morbidity. 
Thus, our results fail to support the perceived association between 
poor treatment outcome and poor patient satisfaction, and support 
earlier	findings	that	patient	experience	and	surgical	outcome	are	two	
separate entities.146 
Studies have shown that overall patient satisfaction after hospital 
admission is usually high.147, 149 In a large retrospective study by Ken-
nedy and coworkers based on University Health System Consortium 
database data from 171 hospitals, favorable surgical outcomes were 
not consistently associated with high patient-satisfaction scores.149 In 
another retrospective study based on Hospital Consumer Assessment 
of Healthcare Providers and Systems data from 2 953 US hospitals, 
Tsai	and	coworkers	found	that	there	need	be	no	trade-off	between	
good-quality care for surgical patients and positive patient experi-
ence.147 Our results are in close agreement with these reports, both 
in terms of patient satisfaction and quality of care. 
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Tsai and coworkers reported that hospital stay was shorter in 
hospitals with the highest patient-satisfaction ratings,147 whereas 
Kennedy and coworkers found no such correlation.149 Our results 
agree with those of the Tsai group, because in Study IV, low overall 
patient satisfaction was associated with somewhat longer hospital 
stay.	Causality	 cannot	 be	 confirmed,	 but	 Study	 IV	 suggests	 that	
prolonged hospitalization or factors leading to longer hospital stays 
may	affect	overall	patient	satisfaction.	We	did	not	assess	changes	
in patient satisfaction occurring between hospital discharge and 30 
postoperative	days,	but	many	factors	may	have	an	effect	on	overall	
patient experience during the recovery period.
An expected association between poor scores in postoperative 
patient-reported assessments and low overall patient satisfaction 
emerged in Study IV. Additionally, poor functional status (mRS score 
≥3)	at	30	days	was	associated	with	low	overall	satisfaction.	Inter-
estingly, patients in this subgroup were sicker (higher preoperative 
ASA scores, Helsinki ASA scores, and Charlson comorbidity scores), 
were older, had longer hospital stays, and had a higher proportion of 
malignant tumors and lower proportion of benign tumors than did 
patients overall who had completed the 30-day follow-up. Plausible 
explanations	are	easy	to	find,	but	surprisingly	no	associations	between	
advanced age/comorbidities and low overall satisfaction appeared in 
the whole cohort. It was beyond the scope of our study further to ad-
dress	any	specific	underlying	factors	behind	the	satisfaction	ratings.	
The association between minor infections and low overall patient 
satisfaction in Study IV is somewhat surprising. The underlying 
mechanism of this association is unclear, as the association lost its 
significance	in	the	absence	of	any	other	complications.	Advanced	
age and longer hospital stay were more prevalent in the subgroup 
of patients with minor infections, both of which could contribute 
to patient satisfaction. Furthermore, a low patient-to-nurse ratio 
(reduced nurse workload) reportedly improves patient satisfaction.180 
Other factors linked with high patient satisfaction comprise increased 
hospitalization frequencies, higher cost of health care and of prescrip-
tion drugs, and still more surprisingly, even increased mortality.181 
These	observations	underline	the	complexity	of	factors	influencing	
the patient experience, many of which were beyond the scope of this 
study. 
Only four patients reported poor or very poor overall satisfaction. 
Of these four, one had an unplanned recraniotomy in the absence of 
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any other major or minor morbidity. A second patient in this group 
had a postoperative unplanned endovascular intervention. Due to the 
low rates of these complications, these are merely case reports, but 
if unplanned reoperations play a role in patient satisfaction ratings, 
informing the patients preoperatively of such a rare possibility could 
improve overall patient satisfaction.
6.4 Limitations of the study
Systematic review
The outcome of patients undergoing emergency neurosurgery is 
largely dependent on the underlying acute illness.182 Despite a vigor-
ous attempt to include studies reporting on only elective craniotomy 
patients, we were unable to fully exclude emergency patients; this was 
due to incomplete information in the original articles. Study designs, 
assessment methods, and reporting principals of the chosen studies 
were highly heterogeneous, making quantitative analyses (meta-anal-
yses) of the results impossible.
Study design
An observational study design does not allow for establishing cau-
sality—as opposed to randomized controlled trials (RCTs). Logistic 
regression was our statistical method where applicable to strengthen 
the results of our observational study, but the observational design 
still mandates a cautious interpretation of results.
Cohort size
The cohort size was relatively small. Our cohort was, however, con-
secutive and unselected, and represents a whole year’s case-mix at a 
tertiary neurosurgical center. Considering the low rate of individual 
complications in elective cranial neurosurgery, to reach statistical 
significance	cohort	size	must	be	substantial.	We	carried	out	the	study	
along with normal clinical work at the department without receiving 
any additional resources. 
Selection bias 
We were able to enroll only 75.8% of all eligible patients. This there-
fore	may	have	influenced	our	results.	Older	and	sicker	patients	may	
be less likely to enroll, but without their consent, further analysis of 
this potential bias was impossible. 
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Data collection
The patient-reported questionnaires and study forms were complete 
for	299	(71.5%)	patients.	A	study	anesthesiologist	filled	in	all	objec-
tive data with systematic manual retrieval from hospital records. 
For statistical analyses, if data were missing, we excluded patients 
analysis by analysis. Perioperative and in-hospital complications data 
recording was complete for all patients. 
Despite at least three attempts to reach each patient, the response 
rate for the 30-day telephone interview was only 81.3% (340 pa-
tients).	To	assess	the	dropout	effect,	we	compared	subgroups	and	
conducted post-hoc analyses based on data from hospital patient 
records obtained at postoperative outpatient-clinic visits. No signif-
icant	differences	were	detectable	as	to	the	distribution	of	sex,	age,	
ASA score, Helsinki ASA score, location of craniotomy, indication for 
surgery, ICU LOS, or hospital LOS. Patients lost to follow-up had a 
higher rate of major complications and unplanned reoperations and 
had higher mRS scores preoperatively, both at hospital discharge and 
at 30 days (Table 24).
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Telephone-
interviewed patients
N=340* ‡ (%)
Lost to follow-up (including 
mortality, ≤30 days)
N=78† (%)
Sex female 215 (63.2) 45 (57.7)
male 125 (36.8) 33 (42.3)
Age (years) mean 55.8 58.6
median 58.0 58.0
ASA score 1 57 (16.8) 10 (12.8)
2 126 (37.2) 26 (33.3)
3 139 (40.9) 27 (34.6)
4 17 (5.0) 12 (19.2)
Helsinki ASA 
score
1 3 (0.9) 1 (1.3)
2 83 (24.4) 11 (14.1)
3 210 (61.8) 41 (52.6)
4 43 (12.6) 25 (32.1)
Preoperative 
mRS  score
0 90 (26.5) 17 (21.8)
1 130 (38.3) 28 (35.9)
2 93 (27.4) 16 (20.5)
3 19 (5.6) 8 (10.3)
4 6 (1.8) 7 (9.0)
5 1 (0.3) 2 (2.6)
Location of  
craniotomy
Infratentorial 80 (23.5) 24 (30.8)
Supratentorial 260 (76.5) 54 (69.2)
Indication for 
surgery
Malignant 101 (29.7) 20 (25.6)
Benign 102 (30.0) 33 (42.3)
Vascular 113 (33.2) 25 (32.1)
Other 24 (7.1) 0 (0.0)
Major 
complication
(excluding 
reoperations)
yes 40 (11.8) 25 (32.1)
no 300 (88.2) 53 (67.9)
Unplanned 
reoperation
yes 12 (3.5) 7 (9.0)
no 326 (95.9) 71 (91.0)
ICU LOS (days) mean 1.2 1.9
median 1.0 1.0
Hospital LOS 
(days)
mean 5.3 6.7
median 5.0 5.0
Table 24. Characteristics of patients completing the 30-day 
telephone interview and patients lost to follow-up.
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*for ASA score, Helsinki ASA score, preoperative mRS score n=339
‡for hospital discharge mRS score n= 328
†for 30-day mRS scores n=72
ASA, American Society of Anesthesiologists; ICU, intensive care unit; LOS, length of stay; mRS, modified Rankin Scale.
Distribution	of	mRS	score	differences	(preoperative	to	30	days)	
remained unchanged after the addition of patients lacking a tele-
phone interview but with the 30-day mRS score from outpatient clinic 
patient records. Results of the post-hoc analyses were similar to the 
original analyses, indicating that failure to obtain complete follow-up 
data neither skewed our results nor altered our conclusions. 
mRS scores
The inter-rater variability of the mRS is low,29-31 but such bias cannot 
be excluded. This shortcoming is, however, probably of minor rele-
vance in terms of conclusions. An anesthesiologist assessed all mRS 
scores to minimize any surgeon-related bias in reporting outcome. 
The mRS may be unable to detect changes in functional status if a 
large proportion of the cohort has high mRS scores at baseline; our 
cohort had 10.3% of the patients preoperatively functionally depen-
dent	(mRS	score	≥3).	
Methods	of	measuring	postoperative	mRS	differed	at	discharge	
(anesthesiologist’s objective assessment) and at 30 days (patient’s 
subjective	reporting	in	a	structured	telephone	interview).	Different	
methods	of	measurement	may	have	influenced	results	because	sub-
Hospital 
discharge mRS 
score
0 127 (38.7) 20 (25.6)
1 83 (25.3) 8 (10.3)
2 62 (18.9) 14 (17.9)
3 30 (9.1) 10 (12.8)
4 23 (7.0) 13 (16.7)
5 3 (0.9) 9 (11.5)
6 0 (0.0) 4 (5.1)
30-day mRS 0 110 (32.4) 15 (20.8)
1 111 (32.6) 13 (18.1)
2 46 (13.5) 8 (11.1)
3 56 (16.5) 8 (11.1)
4 11 (3.2) 11 (15.3)
5 6 (1.8) 7 (9.7)
6 0 (0.0) 10 (13.8)
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jectivity cannot be excluded in telephone-interview results, but this 
difference	has	no	obvious	implications	for	their	interpretation.	
Furthermore, hospital discharge data, including mRS score, was 
recorded before an unplanned reoperation in 7 patients and after the 
reoperation in 12. No additional major complications resulted from 
the reoperations, but we cannot exclude their contribution to the 
30-day mRS score. In fact, 30-day mRS was available for 5 of these 
patients, and for 3 patients (60%) mRS score had increased from 
hospital discharge to 30 days. Of patients with major complications, 
75%	had	an	mRS-score	difference	>0	at	discharge	and	66%	at	30	
days. 
Additional confounding factors may have had an impact on the 
30-day mRS scores, as it was beyond the scope of our study to record 
and	assess	the	effect	of	postoperative	rehabilitation	or	possible	health	
problems leading to admissions in other hospitals during the 30-day 
follow-up.
Outcome measures
Silent strokes were included among major complications, but accord-
ing	to	their	definition,	they	are	not	expected	to	have	any	effect	on	
functional status. Thus, to exclude the possibility of bias in analysis in 
regard to silent strokes, we repeated the analyses with silent strokes 
excluded from major complications; the results remained unchanged, 
indicating that including silent strokes did not skew results. 
Categorizing reoperations as complications may be disputed. We 
chose to do so, as a craniotomy or any other procedure involving the 
brain	potentially	affects	functional	outcome	and	may	lead	to	addi-
tional surgical complications. The indication for a reoperation is often 
very	different	from	that	for	the	original	surgery,	however.	The	most	
common reasons for a reoperation are to remove a residual lesion or 
to	perform	a	small	reconstructive	procedure	such	as	repair	of	a	fistula	
causing CSF leakage. Thus, many of the reoperations were relatively 
minor compared to the original surgery.
Additionally, some of the study outcomes were patient-reported. 
For example, subjective visual disturbances came from the patients’ 
questionnaire at discharge. No clinical neurological-status examina-
tion	tested	for	objective	findings	affecting	vision,	such	as	paresis	of	
the	oculomotor	nerve	or	defects	of	the	visual	field.	Thus,	the	subjec-
tive	visual	disturbances	reported	may	merely	reflect	minor	transient	
postoperative conditions such as edema of the eyelids or blurriness 
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of vision due to strong opioid painkillers. The same limitations apply 
to dysphasia/dysarthria and dysphagia. It is noteworthy, however, 
that this may have biased the results towards over-reporting outcome 
events, not underreporting them. 
Use of composite outcome measures can draw criticism as an arti-
ficial	attempt	to	achieve	statistically	significant	results	in	a	relatively	
small cohort. The rationale behind this decision was to establish the 
suitability of mRS as a measurement for overall short-term outcome 
in elective cranial neurosurgery, not merely an indirect means of 
measuring the hemiparesis rate. 
Length of follow-up
Our follow-up can be considered short. Our aim, however, was to 
study	surgery-related	complications	and	their	effect	on	the	mRS.	A	
long	follow-up	may	reflect	functional	changes	attributable	to	rehabil-
itation or progression of the underlying disease, such as malignancy. 
Patient satisfaction
Patient	satisfaction	was	measured	on	a	five-tier	scale	from	very	poor	
to excellent in the 30-day telephone interview. Patients may be more 
inclined to report better satisfaction in person, and even over the 
telephone	this	“courtesy”	bias	cannot	be	excluded.	We	attempted	to	
minimize	this	effect	by	having	a	study	anesthesiologist,	not	a	member	
of	the	department’s	clinical	staff	who	was	involved	in	direct	patient	
care, conducting the interview. Furthermore, events between hospital 
discharge and the 30-day telephone interview may have contribut-
ed to the satisfaction ratings, as all patients who responded to the 
telephone interview were discharged at the latest on postoperative 
day 23.
Missing data
We were unable to obtain complete data for all study patients. 
Altogether	119	(28.5%)	patients	had	incompletely	filled-in	patient	
questionnaires and study forms. In-hospital complications, however, 
were manually retrieved from patient records; thus complete data 
were available for the entire cohort. Loss to follow-up at 30 days 
was 68 (16.3%) patients. Post hoc analyses on 30-day mRS scores 
available for 62 of these patients from patient records indicated no 
significant	bias	due	to	the	dropout	effect.	For	each	statistical	analysis,	
patients with unavailable data were excluded. 
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7. CLINICAL IMPLICATIONS  
 AND FUTURE PERSPECTIVES
None of the current preoperative risk-assessment scores in elective 
cranial neurosurgery receive the support of compelling evidence. It 
is clear that large, well-designed prospective studies must clarify the 
role of existing risk-assessment scores, or enable the development of 
new,	neurosurgery-specific	preoperative	scores.	Study	II	validated	
the use of the Helsinki ASA score, which proved more accurate in 
preoperative	stratification	of	elective	craniotomy	patients	than	did	
the original ASA score. The highest value of the Helsinki ASA score 
was, here, possibly in serving as part of a composite risk predictor for 
systemic and infectious complications or, in future, serving as a part 
of	a	specific	risk-prediction	score	for	cranial	neurosurgical	patients.	
Furthermore, preoperative functional status (mRS score) and burden 
of comorbidity (Charlson comorbidity score) also showed potential 
as tools in preoperative risk assessment, but no score was suitable 
for use as a sole risk predictor in neurosurgical patients. The value 
of individual preoperative patient characteristics and laboratory 
measurements as risk predictors is low, but they may still be useful 
components of composite risk predictors. Hopefully, our results will 
encourage the design and execution of international multi-center 
studies	aimed	at	developing	a	neurosurgery-specific	preoperative	
risk-assessment score.
The	current	study	provides	the	first	prospective	data	on	com-
plication types and rates in an unselected cohort of adult elective 
craniotomy patients, and as such may provide tools for preoperative 
information and patient-centered decision-making. An international 
consensus on neurosurgical outcome reporting, together with pro-
spective data collection, is crucial not only for benchmarking, but 
also for meaningful and reliable comparisons between treatment 
centers. Striving for such a consensus should be a priority for the 
neurosurgical community, considering the increasing demand for 
public outcome reporting. The launch of the N2QOD cranial module 
could	be	the	first	step	in	this	direction.	
The mRS as an outcome measure in cranial neurosurgery is based 
not	on	evidence	but	on	tradition.	This	study	was	the	first	prospective,	
unselected study that evaluated applicability of the mRS score for 
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such	use.	The	inconsistency	of	mRS	scores	and	mRS-score	differences	
with regard to recorded adverse events discourages use of mRS as an 
outcome	measure,	regardless	of	some	correlation	with	new	CNS	defi-
cits in Study III. In the era of patient-centered health care and patient 
safety, modern neurosurgery needs a more accurate and reliable tool 
for outcome reporting, and this remains a topic for future research.
In our cohort, patient questionnaires and study forms provided 
data which was then manually transferred to electronic form. Elec-
tronic data collection is available today in most centers, including 
ours. It can facilitate prospective data collection for large patient 
cohorts183 or even be implemented as a routine protocol for all elec-
tive craniotomy patients, as in the N2QOD.184 Web-based surveys can 
provide patient-reported data, but technological innovations such as 
tablet computers should be embraced and harnessed to serve pre-
operative patient information and patient-reported data collection. 
The feasibility of patient satisfaction data does not justify their use 
as a surrogate for quality of care. The rate of high patient satisfaction 
is almost similar for all patients and for patients with major postoper-
ative complications. No association between low patient satisfaction 
and reported complications was detectable in Study IV. Underlying 
factors contributing to patient experience and satisfaction are com-
plex, and informing patients of the possibility of major complications 
could further improve patient satisfaction. 
Patient-reported outcomes and their composite scores are 
promising future tools for outcome reporting. In the current study, 
few individual PROs served to test the feasibility and accuracy of 
patient-reported data. Study V showed that even individual PROs or 
their simple combinations can be implemented in clinical practice 
to provide patient-centered outcome data and improve both patient 
safety	and	quality	of	care.	Tailored,	neurosurgery-specific	PROMs	are	
still lacking, and our results should spark interest in future research 
in	the	field.	The	use	of	patient-reported	variables	in	preoperative	risk	
assessment in neurosurgery remains an inspiring topic for future 
research aimed at improving patient safety and quality of care in 
elective intracranial surgery.
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8. CONCLUSIONS
The following conclusions are based on the results of Studies I-V:
1. Evidence as to the applicability of preoperative risk-assessment 
methods in elective craniotomy patients was scarce. Receiving 
the most support in the literature was the Karnofsky Performance 
Score, with some positive results also for the ASA score and 
Charlson comorbidity score in selected patient populations. None 
of the existing preoperative scores alone was suitable for predict-
ing overall short-term outcome in elective cranial neurosurgery.
2. Rates of mortality and individual major complications in our 
cohort were moderately low. No single preoperative variable 
could reliably predict individual complications. Composite risk 
predictors and composite outcome measures may best serve in 
clinical use.
3. The Helsinki ASA score was more accurate and reliable in 
predicting systemic and infectious complications than was the 
original ASA score. Combinations, rather than any single pre-
operative variable or score, seem most suitable for preoperative 
risk	stratification	of	elective	craniotomy	patients.	
4. The mRS score was a vague outcome measure in elective cranial 
neurosurgery.	Postoperative	mRS	scores	and	mRS-score	differ-
ences	failed	to	reliably	reflect	the	occurrence	of	postoperative	
adverse events. PROs were promising tools for patient-centered 
outcome reporting in elective cranial neurosurgery, and their 
implementation in clinical practice seems feasible, even in a busy 
tertiary neurosurgical center. Large prospective studies should 
validate	these	findings	and	guide	the	development	of	more	suit-
able outcome measures for elective craniotomy patients.
5. Patient satisfaction after elective cranial neurosurgery was high, 
even among patients with major complications. Patient dissat-
isfaction showed no association with a complicated outcome. 
In quality-of-care comparisons, patient satisfaction should not 
serve as a proxy for outcome.
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12. APPENDICES
Appendix 1. Preoperative patient questionnaire
1. Basic information:
 • Name
 • Social security number
 • Date of filling the questionnaire
 • Planned date for operation
 • Age
 • Weight, height
 • Place of residence prior to the operation (home, hospital, assisted residency,  
 health care center, nursing home)
2. Previous health (no/yes; diagnosis and when diagnosed)
 • Heart condition
 • Arrhythmias
 • Dyspnea
 • Chronic lung illness
 • Atherosclerosis, carotid artery stenosis, claudication
 • Deep vein thrombosis, pulmonary embolism, thrombogenic condition
 • Stroke, intracranial hemorrhage
 • Cancer
 • Diabetes
 • Epilepsy
 • Other significant illness
3. How do you rate your general health at the moment (excellent-good-average-poor-very 
poor), why? 
4. Smoking
 • Never
 • Yes, how many cigarettes/day, how many years?
 • Ceased smoking, how many cigarettes/day, how many years, when ceased?
5. Alcohol consumption during past 7 days
 • None
 • Moderate: women 1-16 doses, men 1-24 doses
 • Excessive: women over 16 doses, men over 24 doses
6. How often do you exercise for at least 20 minutes, enough to feel short of breath and 
break a sweat?
 • Cannot exercise due to illness or condition
 • Less often than once a week
 • Once a week
 • 2-3 times a week
 • 4 times a week or more 
7. How do you rate your physical fitness at the moment (excellent-good-average-poor-
very poor)?
8. Can you climb to flights of stairs without stopping? 
 • Yes
 • No, why?
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Appendix 2. Postoperative patient questionnaire
1. Basic information
 • Name
 • Social security number
2. Postoperative information
 • Date of operation
 • Date of hospital discharge (from Department of Neurosurgery)
 • Place of residence after hospital discharge (home, hospital, assisted residency,  
 health care center, nursing home)
3. Postoperative neurological deficits/symptoms
 • Short description of symptoms
4. Postoperative symptoms (No/Yes, what?)
 • New hemiparesis
 • Postoperative visual impairment
 • Speaking difficulties (Dysphasia, Aphasia)
 • Swallowing difficulties (Dysphagia)
 • Local wound infection, meningitis
 • Other infections
 • Stroke, cerebral ischemia
 • Pneumonia
 • Pulmonary embolism
 • Heart attack
5. Do you think your functional status has changed after the operation (No/ Yes, how?)
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Appendix 3.  30-day structured telephone interview  
1. Basic information
 • Patient name
 • Social security number
 • Date of call
2. Place of residence at the time of the interview (home, hospital, assisted residency, 
health care center, nursing home)
3. 30-day mRS31
4. How do you rate your general health at the moment (excellent-good-average-poor-very 
poor)?
5. Do you have any persisting postoperative symptoms? (No/Yes, what?) Are they severe/
mild?
6. Which of the following best describes your overall satisfaction in the neurosurgical 
care during this hospitalization? Excellent, good, satisfactory, poor, or very poor.
